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Samenvatting NL
Het huidige rapport omvat een literatuurstudie naar diverse aspecten die gerelateerd zijn aan de
immuun competentie van landbouwhuisdieren. Deze aspecten, die in hoofdstuk 1 geïntroduceerd
worden, zijn:
 Het aantonen van verbanden tussen functionele componenten in diervoedergrondstoffen en de
expressie van genen/biologische processen, die van invloed zijn op de darmgezondheid van
landbouwhuisdieren;
 Het beschrijven van modellen die gebruikt kunnen worden bij onderzoek naar effecten van
voedingsinterventies op immuun gerelateerde kenmerken in landbouwhuisdieren;
 Het samenvatten van effecten van nutritionele interventies in de maternale, neonatale en post-
neonatale fase op de ontwikkeling van het aangeboren en verworven immuunsysteem;
 Een literatuurstudie naar de relatie tussen het immuunsysteem in de darm en in de bovenste
luchtwegen, waarbij ingegaan wordt op de vraag hoe voedingsinterventies het immuunsysteem in
de bovenste luchtwegen kunnen ondersteunen.
Summary UK
The current study covers a review of literature regarding a number of topics related to immune
competence in farm animals, which are introduced in chapter 1. These topics are:
 A demonstration of the relationship between functional feed components and the expression of
genes/biological processes that are involved in gut health of farm animals;
 A description of available models, that can be used to investigate the effects of nutritional
interventions on immune related parameters in animals;
 A review of the effects of nutritional interventions in the maternal, neonatal and post-neonatal
phase on the development of the innate and acquired immune system;
 A review of the relationship between the immune system in the gut and in the upper airways,
whereas the question will be addressed how the immune system in the upper airways can be
affected by nutritional interventions.
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Foreword
Feed4Foodure is a public-private partnership between the Dutch Ministry of Economic Affairs, a
consortium of various organizations within the animal production chain and Wageningen UR Livestock
Research. Feed4Foodure aims to contribute to sustainable and healthy livestock farming in the
Netherlands, simultaneously strengthening our competitive position on the global market. The
Feed4Foodure program line “Nutrition, Intestinal Health, and Immunity”, aims to contribute to a
reduction in the use of antibiotics in livestock farming by increasing general health and disease
resistance. The main goals are to develop innovative measurement techniques and to test new health-
promoting nutritional additives in the field of gut health and immunity.
The current study covers a review of literature regarding a number of topics related to the focus area
of the Feed4Foodure program line “Nutrition, Intestinal Health, and Immunity”. These topics are:
The impact of functional feed components on the expression of genes/biological processes that are
related to gut health of farm animals;
Available models, that can be used to investigate the effects of nutritional interventions on immune
related parameters in animals;
The effects of nutritional interventions in the maternal, neonatal and post-neonatal phase on the
development of the innate and acquired immune system;
The relationship between the immune system in the gut and in the upper airways, and the possibilities
to affects the immune system in the upper airways by nutritional interventions.
For the current study, scientist of Wageningen UR Livestock Research, Wageningen University and
Utrecht University worked together with representatives from the various private partners, including
Agrifirm, ForFarmers, Nutreco, De Heus, Denkavit, and Darling Ingredients International. The authors
thank the industry partners of the project team for their worthwhile input.
Dr. Mari Smits, leader Feed4Foodure program line “Nutrition, Intestinal Health, and Immunity”.
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Samenvatting
Besmettelijke dierziekten hebben een sterk remmend effect op het welzijn van dieren, het efficiënt
gebruik van nutriënten en de ecologische footprint van de dierlijke productie. Voeding kan bijdragen
aan het vergroten van de immuun competentie en daarmee aan het beperken van de incidentie van
ziekten. Immuun competentie wordt gedefinieerd als het vermogen van het immuunsysteem om op
adequate wijze te reageren op een antigene stimulus door middel van een evenwichtige
immuunrespons met een goede balans tussen tolerantie en ontsteking. Het belang van immuniteit
versterkende diervoeding is toegenomen, omdat bacterieremmers, anti-parasitaire toevoegmiddelen
en sommige andere additieven die de diergezondheid bevorderen omwille van de volksgezondheid niet
meer toegevoegd worden aan het voer.
Het huidige rapport omvat een literatuurstudie naar diverse aspecten die gerelateerd zijn aan de
immuun competentie van landbouwhuisdieren. Deze aspecten, die in hoofdstuk 1 geïntroduceerd
worden, zijn:
 Het aantonen van verbanden tussen functionele componenten in diervoedergrondstoffen en de
expressie van genen/biologische processen, die van invloed zijn op de darmgezondheid van
landbouwhuisdieren;
 Het beschrijven van modellen die gebruikt kunnen worden bij onderzoek naar effecten van
voedingsinterventies op immuun gerelateerde kenmerken in landbouwhuisdieren;
 Het samenvatten van effecten van nutritionele interventies in de maternale, neonatale en post-
neonatale fase op de ontwikkeling van het aangeboren en verworven immuunsysteem;
 Een literatuurstudie naar de relatie tussen het immuunsysteem in de darm en in de bovenste
luchtwegen, waarbij ingegaan wordt op de vraag hoe voedingsinterventies het immuunsysteem in
de bovenste luchtwegen kunnen ondersteunen.
Het combineren van informatie over enerzijds de chemische kenmerken van natuurlijke bioactieve
stoffen en anderzijds hun mogelijke effecten op expressie van genen die betrokken zijn bij
darmgezondheid kan bijdragen aan het voorspellen van hun biologische activiteiten in het dier zelf.
Dergelijke informatie is van veel natuurlijk voorkomende bioactieve stoffen vastgelegd in online
beschikbare databases en op basis hiervan kunnen bioactieve componenten geselecteerd worden die
heel gericht onderzocht kunnen worden in dierexperimenten. Hoofdstuk 2 geeft een overzicht van
genexpressie datasets, die gekoppeld zijn aan twee datasets waarin informatie over
diervoedingsstudies is opgeslagen. Ook bevat dit hoofdstuk een handleiding die beschrijft hoe de
informatie in deze databases te gebruiken is om - op basis van de chemische samenstelling van de
betreffende bioactieve stof, die de potentie heeft om de expressie en functie van specifieke genen en
processen te beïnvloeden – te voorspellen welk mogelijk effecten er kunnen zijn op de
darmgezondheid. Hoofdstuk 3 beschrijft de kenmerken, mogelijke toepassingen en voordelen van
verschillende typen in situ, ex vivo, in vitro en in vivo modellen, die gebruikt kunnen worden voor het
onderzoeken van immuno-modulerende onderzoeksvragen. In dit hoofdstuk worden de voordelen en
beperkingen van de meeste modellen besproken. De nutritionele interventies die rechtstreeks of
indirect (via de microbiota) van invloed zijn op de ontwikkeling van het aangeboren en verworven
immuunsysteem, zowel in de maternale, neonatale als post-neonatale fase, worden besproken in
hoofdstuk 4.
Het is de vraag of voedingsinterventies, naast een effect op het immuunsysteem in de darm,
gelijktijdig ook een effect kunnen hebben op het immuunsysteem van de bovenste luchtwegen. Deze
vraag komt aan de orde in hoofdstuk 5.
In hoofdstuk 2 wordt geconcludeerd dat de hoeveelheid databases met genexpressie data en andere
‘omics’ data in openbare bio informatica databases snel toeneemt. Het koppelen van dergelijke data
afkomstig van diervoedingsexperimenten aan die van ‘omics’ onderzoek gericht op darmgezondheid,
zoals in deze studie is uitgewerkt voor het probioticum L. plantarum, kan de zoektocht naar nieuwe en
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alternatieve diervoedingsadditieven in de juiste richting sturen. Daarnaast kan een dergelijke integrale
benadering leiden tot de ontdekking of verbetering van bioactieve componenten. Tevens kan hierdoor
het gebruik van dure diermodellen bij het verwerven van de eerste inzichten m.b.t. de potentie van
specifieke componenten als nieuw diervoederadditief beperkt worden.
In hoofdstuk 3 zijn de diverse soorten in vitro, ex vivo, in situ en in vivo modellen beschreven. Bij de
in vitro modellen wordt onderscheid gemaakt tussen primaire cellen, epitheliale “mini-darmen”, cel
culturen (een, twee- en driedimensionaal) en darmen-op-een chip. De ex vivo modellen worden
onderverdeeld in perfusiesystemen, de omgekeerde zaktechniek, de Ussing kamer, de in vitro orgaan
cultuur (IVOC, zowel gepolariseerd als niet-gepolariseerd), de nieuwe gepolariseerde ex vivo orgaan
cultuur, de IVOC in de Ussing kamer, de precieze weefselsnede plakjes (PCTS) en het varkensdarm
model. Voorbeelden van in situ modellen zijn het darmlus model en de techniek, waarbij segmenten in
de dunne darm doorgespoeld worden (SISP). Tot slot worden sommige in vivo modellen kort
besproken. Het hangt van de (wetenschappelijk) vraagstelling af welk model het beste gebruikt kan
worden. Hoewel tot nu toe nog niet alle modellen gebruikt zijn voor onderzoek naar immuniteit van
mucosaweefsel, zijn alle modellen in principe wel in staat om met behulp van mucosaal weefsel en/of
darmvloeistof het effect van interventies op immunologische processen te meten.
Hoofdstuk 4 beschrijft de directe en indirecte (via de microbiota) effecten van voedingsinterventies op
de ontwikkeling van het aangeboren en verworven immuunsysteem, zowel in de maternale, neonatale
en post-neonatale fase. Met betrekking tot voedingsinterventies in de maternale fase kan
geconcludeerd worden dat er positieve transgenerationele effecten op de darmgezondheid en immuun
competentie van het nageslacht zijn aangetoond bij zowel zoogdieren (muizen, ratten, varkens,
mensen) als bij pluimvee. In deze fase zijn interventies uitgevoerd met vetzuren, zeewierextracten,
pre- en probiotica, vitaminen en mineralen. De interventies verschillen in werkingsmechanisme.
Afhankelijk van het type interventie zijn er effecten gemeten op de samenstelling van de microbiota,
aantal en activiteit van specifieke immuun cellen, morfologie van de darmwand en de expressie van
genen die betrokken zijn bij een immuunrespons. Sommige toevoegingen aan het voer van de
ouderdieren resulteerden in verbeterde technische resultaten of een lagere incidentie van diarree bij
de nakomelingen. Dergelijke transgenerationele effecten zijn aangetoond bij toevoeging van
zeewierextract, Saccharomyces cerevisiae, zink en β-caroteen. Slechts een heel beperkt aantal studies
rapporteerden transgenerationele effecten van de interventies op de expressie van genen die
betrokken zijn bij immuun competentie. Alleen in studies, waarin omega-3 vetzuren of
vitaminen/mineralen werden toegevoegd zijn deze effecten gemeten. Toevoeging van specifieke
vetzuren aan maternale voeders, met name vetzuren afkomstig uit visolie, hadden een sterk positief
effect op diverse aspecten van de immuun competentie van de nakomelingen. Op basis van deze
resultaten kan daarom gesteld worden dat beïnvloeding van het vetzuurprofiel van het voer van
ouderdieren veel perspectief biedt voor verbetering van de immuun competentie van de
nakomelingen.
Op basis van de studies die gericht waren op het effect van voedingsinterventies op de immuun
competentie in de neonatale fase van biggen kan vastgesteld worden dat met name prebiotica en
bloedplasma voor deze diercategorie potentiële additieven zijn. Aanbevolen wordt om deze
interventies in vervolgonderzoek mee te nemen. Uit onderzoek met jonge kuikens bleek dat het
verstrekken van tarwe/sojaschroot voeders (in vergelijking met maïs/sojaschroot of
tarwe/rogge/sojaschroot voeders), het toevoegen van de zwavelhoudende aminozuren methionine +
cysteine boven het niveau dat nodig is voor het bereiken van maximale dierperformance, en het
verstrekken van vitamine E (100 IU/kg) samen met selenium (0,2 ppm) in vergelijking met een voer
dat geen vitamine E en selenium bevatte, positieve effecten had om immuun gerelateerde parameters
(o.a. cytokines, T cellen en productie van antilichamen). In deze literatuurstudie zijn ook humane
studies verwerkt. In deze studies met baby’s is met name gekeken naar het effect van prebiotica (o.a.
oligosachariden), probiotica (o.a. lactobacilli en bifidobacteriën) en langketenige onverzadigde
vetzuren.
Uit onderzoek naar voedingsinterventies in de post-neonatale fase bleek dat het toevoegen van
glutamine de integriteit van de darmwand bevorderde en het aantal CD4+ cellen in het bloed
verhoogde. Toevoeging van kruiden en bioactieve plantenstoffen, o.a. zwarte komijn, chitosan en
quercitine, verbeterden de darmintegriteit, de lokale en systemische immuunrespons, de
samenstelling van de microflora in de darm en de dierprestaties. Bestendig zetmeel bleek t.o.v.
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verteerbaar zetmeel een aanzienlijk gunstig effect te hebben op immunologische processen in het
colon van varkens en op de samenstelling van de microflora. Bepaalde probiotica (o.a. Bacillus subtilli
en Lactobacillus Bulgaricus) verbeterden de immuun competentie, zoals bleek uit een hoger serum
IgG en IgA gehalte, een verlaagd gehalte van de pro-inflammatoire cytokine IL-8, verlaagde aantallen
clostridia en coliformen in de blinde darm en langere darmvilli. Toevoeging van antimicrobiële eiwitten,
o.a. buforin II en lysozym, verbeterden de dierprestaties en de darmintegriteit en verminderden de
fecale uitscheiding van clostridia, E. coli en coliformen.
De waargenomen positieve effecten van verhoogde aminozuurgehalten in het voer op de immuun
competentie kunnen toegeschreven worden aan het effect dat ze hebben op DNA methylatie, activatie
en proliferatie van lymfocyten, NK cellen en macrofagen. Kruiden en bioactieve plantenstoffen hebben
een effect op de lokale immuunrespons (minder macrofagen en neutrofielen in de darminhoud) en op
de systemische immuunrespons (minder TNF-alfa, haptoglobine, witte bloedcellen en lymfocyten in
het serum) na een bacteriële challenge. De positieve effecten van bloedplasma op de immuun
competentie van jonge biggen hangen in sterke mate samen met het IgG gehalte van bloedplasma.
Het gunstige effect van meervoudig onverzadigde vetzuren hangt samen met een vermindering van
ontstekingsreacties (minder macrofagen en T cellen) en met een verminderde acute fase respons.
Bovendien stimuleren ze de productie van antilichamen. Antimicrobiële eiwitten hebben een direct
effect op de samenstelling van de microbiota door het doden van schadelijke bacteriën (o.a. E. coli) of
door te voorkomen dat ze zich aan mucosale epitheelcellen hechten. Daarnaast zijn antimicrobiële
eiwitten in staat om het aantal gobletcellen te verhogen, evenals de expressie van tight junction
eiwitten in de darmwand van het jejunum en ileum. Deze tight junction eiwitten beschermen de
mucosa tegen beschadigingen, stabiliseren de mucus laag en bevorderen herstel van het epitheel.
Op basis van deze studie kan geconcludeerd worden dat het voorkómen van deficiënties aan
aminozuren, mineralen en vitaminen in het voer een belangrijke voorwaarde is voor een goede
werking van het immuunsysteem. Uit de literatuur blijkt dat voedingsinterventies met pre- en
probiotica, bioactieve plantenstoffen, antimicrobiële eiwitten, bloedplasma en omega-3 vetzuren het
meeste perspectief bieden om de immuun competentie van landbouwhuisdieren te verbeteren.
In de huidige literatuur is nog nauwelijks gekeken naar het effect van voedingsinterventies op de
expressie van genen die betrokken zijn bij immunologische processen. Ook is de genoom sequentie
techniek nog nauwelijks toegepast in dit type onderzoek, zodat er nog zeer weinig bekend over het
effect van deze interventies op verschuivingen in de totale microflora. Aanbevolen wordt om deze
technieken in toekomstige studies toe te passen.
In hoofdstuk 5 komt de interactie tussen de darm- en luchtwegimmuniteit aan de orde. De immuun
competentie van de diepere luchtwegen (trachea, primaire bronchiën en longen) blijkt niet wezenlijk
beïnvloed te kunnen worden door voedingsinterventies. Het mucosale immuunsysteem van de
bovenste luchtwegen (neusholte, farynx en larynx) zijn echter gedeeltelijk verbonden met het
mucosale immuunsysteem van de darm. Een orale vaccinatie (met een cholera toxine) bleek niet
alleen in het maagdarmkanaal de IgA productie te vergroten, maar ook  o.a. in de bovenste
luchtwegen. Immunologische weefsel in het hoofd/nek gebied bevindt zich vooral in tonsillen,
lymfknopen en lymffollikels. Het grootste contactoppervlak tussen het voedsel, neusinhoud en het
immuunsysteem bevindt zich in het gebied waar neus en mond samenkomen. Inductie van een
mucosale IgA reactie kan ook al in het immunologische weefsel van de mond en keel (denk aan de
amandelen) plaatsvinden. Het is daarmee waarschijnlijk dat voedingscomponenten/additieven tijdens
het passeren van deze weefsels in de mond- en keelholte, invloed op het mucosale immuunsysteem
van de bovenste luchtwegen kunnen uitoefenen.  Luchtweg pathogenen en luchtallergenen, die in
neusafscheiding aanwezig zijn, kunnen terecht komen in de darm en daar een effect hebben op het
immuunsysteem. Dit kan resulteren in immunologische reacties in zowel de luchtweg- als darmmucosa
als gevolg van circulerende specifieke B-cellen. Een challenge met pathogenen vanuit keel/mond kan
resulteren in de productie van IgA door het mucosale weefsel van de bovenste luchtwegen. Secretoir
IgA (sIgA) is een niet-inflammatoire immunoglobuline, dat in staat is te voorkomen dat pathogenen
mucosale weefsels binnen te dringen (neutralisatie), zonder dat hierbij een ontstekingsreactie op gang
komt, met mogelijk nadelige gevolgen voor de gastheer. Voedingsinterventies die de productie van
IgA bevorderen, kunnen bijdragen aan het ondersteunen van het immuunsysteem, zowel in de
bovenste luchtwegen, als in de darm en illustreren daarbij hun immuun competentie bevorderende
activiteit. Uit de experimenten die in deze studie zijn beschreven blijkt dat toevoeging van Bacillus
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subtillus, Saccharomyces cerevisiae, chitosan, rijstevoermeel, glutamine en bloedplasma aan het voer
resulteerde in een verhoogde IgA productie. In ons instituut is een groot aantal voeradditieven getest
als potentiele vervanger van antimicrobiële groeibevorderaars (AMGB). Het betrof o.a. levende gisten,
mengsels van organische zuren, lecithinen, boterzuur, humuszuur, bioactieve plantenstoffen en
prebiotica. In al deze experimenten werd naast dierprestaties ook het aantal veterinaire
behandelingen en uitgevallen biggen als gevolg van luchtweginfecties geregistreerd. In de meeste
experimenten was het niveau van veterinaire behandelingen en uitval vanwege luchtweginfecties te
laag om verschillen tussen behandelingen statistisch te kunnen toetsen, of was er geen aantoonbaar
effect van de interventie. De enige uitzondering vormde een interventie met een mengsel van
middellange vetzuren (Aromabiotic). Geen enkele big die het voer met Aromabiotic kreeg ontving een
veterinaire behandeling tegen luchtwegaandoeningen, terwijl 7 van de 220 biggen in zowel de
negatieve als positieve (behandeling met AMGB) controle groep veterinair behandeld werden. Er is
behoefte aan meer experimenten, die specifiek het effect onderzoeken van voedingsinterventies op de
immuun competentie in de bovenste luchtwegen.
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Summary
Infectious diseases greatly impair animal welfare and efficiency of nutrient use and thus the
environmental footprint of animal production. Nutrition may aid in minimising the incidence of
diseases by enhancing immune competence. Immune competence is defined as the ability of the
immune system to respond adequately on an antigenic stimulus by an appropriate immune response
with a balance between tolerance and inflammation. The importance of immune competence
enhancing nutrition becomes even more critical as anti-bacterials, anti-parasitics and other additives
that promote animal health are eliminated due to consumer demands.
The current study covers a review of literature regarding a number of topics related to immune
competence in farm animals, which are introduced in chapter 1. These topics are:
 A demonstration of the relationship between functional feed components and the expression of
genes/biological processes that are involved in gut health of farm animals;
 A description of available models, that can be used to investigate the effects of nutritional
interventions on immune related parameters in animals;
 A review of the effects of nutritional interventions in the maternal, neonatal and post-neonatal
phase on the development of the innate and acquired immune system;
 A review of the relationship between the immune system in the gut and in the upper airways,
whereas the question will be addressed how the immune system in the upper airways can be
affected by nutritional interventions.
Combined information about gene-chemical associations retrieved from on-line available databases
can be used to predict the in-vivo biological activity of natural occurring chemical compounds. These
knowledge can be used to select bioactive components for further assessment in animal experiments.
In chapter 2, an overview of gene-expression datasets of feed-related studies in farm animals posted
in two databases were discussed. Secondly, a tutorial is provided how to explore all information in
these databases in order to (in-silico) predict chemical compounds and additives that have potential to
steer the expression and function of specific genes/processes in the GI tract of farm animals.
Chapter 3 describes the characteristics, applications and benefits of different types of in situ, ex vivo,
in vitro as well as in vivo models that can be used to investigate immuno modulating research
questions. Advantages and limitations of most models have been indicated.
The nutritional interventions that directly or indirectly (via the microbiota) engage the optimal
development of the innate and acquired immune system, both in the maternal, neonatal and post-
neonatal phase are reviewed. The results of this literature search are described in chapter 4.
It can be questioned whether nutritional interventions may not only affect the immune system in the
gut, but simultaneously the immune system of the upper airways. This question is discussed in
chapter 5.
In chapter 2, it is concluded that the amount of gene expression databases and other “omics” data in
public bioinformatics databases still increases rapidly. Integration of such data from feed-related
studies, as well as from other “omics” research studying the function of the gut, as was done in this
study for the probiotic bacterium L. plantarum , can push the search for new and/or alternative feed
additives in the right direction. Besides, such an integrative approach may lead to the discovery or
improvement of new functional compounds, it may also reduce the use of expensive animal models to
gain the primary data needed to prove the potential of specific compounds as functional feed additives
in an early stage of their development traject.
In chapter 3, the principles of in vitro, ex vivo, in situ and in vivo models are described. The following
in vitro models are distinguished: primary cells, epithelial “mini guts”, cell cultures (one-, two- and
three-dimensional), and intestines-on-a-chip. The ex vivo models are subdivided in the perfusion
system, the
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everted sac technique, the Ussing chamber, in vitro organ culture (IVOC, both polarized or non-
polarized), the novel polarized ex vivo organ culture, the IVOC in the Ussing chamber, the precision
cut tissue slices (PCTS), and the porcine intestinal model. The intestinal loop model and the small
intestinal segment perfusion (SISP) are representatives of in situ models. Finally, some in vivo models
are briefly described. It depends on the (scientific) question to be answered, which model should be
used. Assessing mucosal immunity had not been applied in all models described, but in principal in all
models mucosal tissues and/or gut fluid samples can be used for measuring immunological responses.
Chapter 4 presents the direct or indirect (via the microbiota) effects of nutritional interventions on the
development of the innate and acquired immune system, both in the maternal, neonatal and post-
neonatal phase. The conclusions regarding the maternal phase are summarized as follows. Trans-
generational effects of maternal dietary interventions on improvement of gut health and immune
competence has been demonstrated in mammals (mice, rats, pigs, humans) as well as in poultry. The
reviewed dietary interventions can be categorized to fatty acids, seaweed extract, pre- and probiotics,
and vitamins and minerals. The dietary interventions showed a variety in modes of action. They could
affect the composition of the microbiota, the numbers or activity of specific immune cells, the gut
morphology, and the expression of genes involved in immune response. In some studies, it was shown
that the maternal dietary interventions resulted in improved animal performance or reduced incidence
of diarrhea of the offspring. These effects were demonstrated for seaweed extract, Saccharomyces
cerevisiae, zinc and β-carotene. Only a few studies reported trans-generational effects on gene
expression. These studies investigated the effects of supplemented omega-3 fatty acids or vitamins
and minerals. Supplementation of maternal diets with specific fatty acids, in particular with fish oil,
showed to have a wide impact on the immune competence of the progeny. Therefore, modulating the
dietary fatty acid profile of maternal diets seems to be a promising intervention for improving immune
competence of the progeny.
Based on the studies that were focused on nutritional interventions in the neonatal phase in pigs, it
can be concluded that in terms of immune parameters (e.g. cytokines) prebiotics and spray dried
plasma could be potential candidates to further investigation. For chickens, evidence of nutritional
effects on improved immune competence was found in supplementation of ‘wheat/soy’ diets
(compared to maize/soy or wheat/rye/soy diets), addition of ‘Methionine and Cysteine’ above the
requirements for maximal growth, as well as ‘vitamin E (100 IU/kg) together with selenium (0.2 ppm)’
vs. an unsupplemented vitamin E/selenium diet (e.g. cytokines, T cells and antibodies). Human infants
were also studied extensively within the context of early life variation and (impact on) immunity. From
these studies we concluded that one must avoid a depletion of vitamins and/or minerals in the diet.
The most abundant investigated nutritional interventions were prebiotics (e.g. oligosaccharides),
probiotics (e.g. lactobacilli and bifidobacteria) and long-chain poly unsaturated fatty acids.
In the post-neonatal phase, it was shown that dietary addition of glutamine improved gut integrity and
the number of CD4+ cells in blood. Herbs or functional components in plants, e.g. black cumin,
chitosan or quercitine, showed to improve gut integrity, local or systemic immune responses,
composition of gut microbiota and performance parameters. Compared to digestive starch, resistant
starch showed to have significant improving effects on immunological pathways in the colon of pigs as
well as on the composition of the microflora. Some probiotics (Bacillus subtillis and Lactobacillus
Bulgaricus) also positively affected the immune competence, as shown by increased serum IgG and
IgA concentrations, less pro-inflammatory cytokine IL-8, decreased numbers of clostridia and
coliforms in the ceaca, and greater villus height. Antimicrobial proteins, e.g. buforin II and lysozyme,
improved performance levels and gut integrity, and reduced faecal excretion of clostridia, E. coli, and
coliforms.
The positive observed effects of amino acids on immune competence can be attributed to their role in
DNA methylation, activation and proliferation of lymphocytes, NK cells, and macrophages. Herbs and
functional plant components have their effects though reduced local (les macrophages and neutrophils
in the ileum) and systemic inflammation (less serum TNF-alpha, haptoglobin, white blood cells and
lymphocytes) after bacterial challenges. The immuno competence improving effects of spray-dried
animal plasma in young pigs is most likely mediated by the IgG component in the plasma. Poly
unsaturated fatty acids exert their effects via reducing inflammatory responses in macrophages and T
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cells, and by reducing the acute phase response. Moreover, it was shown that they stimulate the
antibody response. Antimicrobial proteins are able to affect the microbial population by directly killing
harmful bacteria (e.g. E. coli) or by preventing binding of bacteria to the mucosal epithelial cells.
Moreover, antimicrobial proteins might stimulate the number of goblet cells and the expression of tight
junction proteins in the jejunum and ileum. These tight junction proteins may protect the mucosa from
insults, stabilize the mucus layer and affect healing of epithelium.
It can be concluded that an important condition for a well-functioning immune system is the
prevention of nutritional deficiencies in terms of amino acids, minerals and vitamins. Based on the
results of this review, pre- and probiotics, functional plant components, antimicrobial proteins, spray-
dried animal plasma, and omega-3 fatty acids seem the most perspective categories of dietary
interventions for improving immune competence of farm animals. Transcriptomics data and microbiota
data based on genome sequencing techniques, however, are hardly available in the reviewed
literature. For a better understanding of the impact of nutritional interventions on immune
competence, the use of these techniques are highly recommended.
Chapter 5 shows the interaction between the gastro-intestinal and airway mucosal immune system. It
is concluded that the lower respiratory tract (trachea, primary bronchi and lungs) is not significantly
modulated by nutritional modulation. The mucosal immune system of the upper respiratory tract
(nasal cavity, pharynx and larynx), however, is partly connected to the mucosal immune system of
the gut. Oral vaccination (with cholera toxin) did not only increase IgA secretion in the upper airways,
but also in the digestive tract and in breast tissue. Immunological tissues in the head/neck area are
mainly structured in tonsils, lymph nodes and lymph follicles. The largest site of contact between food
and nasal contents and the immune system occurs in the area where nose and mouse come together.
The mouth and throat are important inductive sites for initiating specific IgA secretion at the mucosal
surfaces of the upper respiratory tract. Airway pathogens and aeroallergens, present in nasal
secretions, can become available in to the intestinal immune system, which may result in immune
effects in both mucosal compartments due to recirculating specific B-cells. A challenge with such
pathogens from mouth and throat is an important trigger for the secretion of IgA at the mucosal
surfaces of the upper respiratory tract. IgA, which is a non-inflammatory immunoglobulin, which can
exclude pathogens from entering the tissues, without promoting inflammation.
It is expected that nutritional interventions that stimulate IgA production might be helpful in
supporting the mucosal immune system, both in the upper airways as well as in the gut, thereby
demonstrating their immune competence enhancing activities. In the current study, it was shown from
literature that dietary addition of Bacillus subtillis, Saccharomyces cerevisiae, chitosan, rice bran,
glutamine, and spray-dried animal plasma resulted in increased secretion of IgA.
In our institute, a large number of feed additives, e.g. live yeast, mixtures of organic acids, lecithin’s,
butyric acid, humic acid, bioactive plant components and prebiotics, were tested as potential replacers
of antimicrobial growth promoters. In all these animal performance experiments, veterinary
treatments and mortality due to airway disorders were registered. In most of the experiments,
however, veterinary treatment and mortality levels were too low for statistical analysis, or were not
affected by the dietary interventions. The only exception was an intervention with a mixture of
medium chain fatty acids (Aromabiotic), with no veterinary treatments in the piglets that received the
Aromabiotic diet, whereas 7 out of 220 piglets were veterinary treated in both the negative and
positive (with antimicrobial growth promoter) control groups. More studies, and probably with a more
tailored design, should be performed to determine the possible contribution of dietary interventions on
the immune competence of the upper airways.
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1 Rationale of the report
The fields of immunology, microbiology, nutrition and metabolism are rapidly converging to induce and
maintain gastro-intestinal health of agricultural animals. Diet has a considerable effect on the
composition of the gut microbiota, and composition and products of the gut microbiota have profound
effects on immune and inflammatory responses. The intestinal microbiota is derived at least in part
from the mother during the birthing process and is modified thereafter by factors such as diet,
antibiotic use, host genetics and other environmental factors.
This suggests that balanced microbial composition results in symbiosis; this provides regulation of
immune and inflammatory responses through anti-inflammatory and/or immunomodulatory dietary
products, which helps maintain homeostasis. Dysbiosis would lead to dysregulation of the immune
system through lack of beneficial microbial products and an increase in virulence factors, which could
leave the host susceptible to inflammation. Dysbiosis could occur through the consumption of a poor
diet, as well as through changes induced by factors such as host genetics, maternal transfer and
antibiotic use. It has been recognized only recently that the gut microbiota can influence immune
function beyond the gut, thereby affecting also immune protection in the upper airways.
Postnatal, bacteria colonize the neonatal intestine immediately, initiating multiple events that affect
the development or functional maturation of the mucosa and gut-associated lymphoid tissues.
Microbe-associated molecular patterns (MAMPs) sensed by pattern-recognition receptors on intestinal
epithelial cells and dendritic cells adjacent to cryptopatches stimulate the further recruitment of B cells
and T cells, causing the cryptopatches to develop into mature isolated lymphoid follicles. The isolated
lymphoid follicles release IgA-producing plasma cells, which are formed through T-cell-dependent and
independent interactions, into the lamina propria. Microbes also cross the epithelium and enter Peyer’s
patches through M cells, from which they are endocytosed by dendritic cells in the sub epithelial dome.
Antigen-loaded dendritic cells in the Peyer’s patch interact with local lymphocytes to induce T-cell
differentiation and T-cell-dependent B-cell maturation in the germinal centre to induce the
development of IgA- producing plasma cells that home to the lamina propria, where they release
dimeric IgA for transport into the intestinal lumen. Dendritic-cell-mediated luminal sampling of
microbial products or transcytosis of bacteria across the epithelium results in antigen loading of lamina
propria dendritic cells, which then migrate through the afferent lymphatics vessels to a draining
mesenteric lymph node to induce differentiation of effector T cells that traffic to the lamina propria.
Sensing of MAMPs stimulates the proliferation of intestinal epithelial cells in crypts, resulting in their
increased depth and, in the small intestine, increased density of Paneth cells. This sensing also arms
the intestinal epithelial cells for release of antimicrobial peptides.
Appropriate activation of an immunological activity of production animals is thus considered important
to become resistant to infectious diseases, in the respiratory and gastro-intestinal tract. Stress
induced by husbandry conditions and management activities can lead to changes in the immune
response resulting in both increased and decreased resistance to opportunistic pathogens. Growth-
promoting antibiotics have been a major tool in modulating host-pathogen interactions and limiting
clinical and subclinical bacterial infections. Regulatory pressures to limit antibiotic use in poultry and
pig production have limited the disease-fighting tools available to poultry and livestock producers.
There is thus a need to evaluate potential antibiotic alternatives to improve both production and
disease resistance in high-intensity food animal production.
The nexus between nutrient metabolism and the immune system occurs at many levels, ranging from
endocrine signalling to direct sensing of nutrients by immune cells. Diet shapes gut microbial
community structure and function, and the microbiota adapts in ways that promote nutrient
processing; the ability of the microbiota to process a given diet affects the nutrient and energetic
value of that diet. The microbiota and immune systems co-evolve: malnutrition affects the innate and
adaptive immune systems as well as the microbiota. The microbiota acts as a barrier to
enteropathogen infection; this barrier function may be disrupted by malnutrition, as well as by
perturbations in immune system function. The microbiota affects nutrient processing by the host,
including the expression of host genes involved in nutrient transport and metabolism. Immune-cell-
associated receptors use information about the local nutrient or metabolite milieu to organize local
immune responses. The dietary intake of nutrients shapes microbial community structure, which, in
turn, changes the nutritional value of the consumed food. Unmodified dietary components are
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absorbed in the intestine, where they can interact with immune cells. Microbial signals in the form of
microbe-associated molecular patterns (MAMPs) modify local mucosal immune responses through
innate signalling pathways such as the inflammasome or TLRs. Microbe-modified dietary components
(such as acetate produced by the fermentation of polysaccharides) provide signals by which the
immune system can monitor the metabolic activities of the microbiota. In turn, feed factors can
directly modifying intestinal microbial ecology.
There is thus a clear need to create more and improved databases for monitoring changing patterns of
food consumption and allowing the identification of new host and microbial biomarkers and mediators
of nutritional status, determining the nutritional value of various feeds, and characterizing the function
of the immune system, including mucosal barrier integrity and mucosal immunity, and the dynamic
operations of the microbiota. These biomarkers should be reliable, robust, relevant and reflect
compromised health, and need to be determined in several body fluids like peripheral blood (serum or
plasma), saliva, urine and stool in sufficient sensitivity and specificity, in small volumes and with the
necessary throughput. Such biomarkers are as yet hardly available. Basic research is required in
relevant model and target species to define such biomarkers based on -omics studies (using
genomics, proteomics and metabolomics tools) combined with bioinformatics (network analyses). For
proper utilization, economically relevant diseases (including respiratory infections in pigs and chicken,
and feed-induced inflammatory bowel diseases in husbandry species) should be analysed for suitable
application of techniques and biomarkers.
Nutritional approaches to counteract the debilitating effects of stress and infection may provide
producers with useful alternatives to antibiotics and increased food safety. Since diet is a major
contributing factor to the health status of agricultural animals, the feed industry should consciously
adapt their available products. This report provides a solid background based on benchmarking the
available literature to accommodate a cost-effective effort to new feed approaches for the industry.
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2 Introduction
Infectious diseases greatly impair animal welfare and efficiency of nutrient use and thus the
environmental footprint of poultry production [1]. Appropriate nutrition becomes even more critical as
anti-bacterials, anti-parasitics and other additives that promote animal health are eliminated due to
consumer demands. Nutrition may aid in minimising the incidence of diseases by enhancing immune
competence. Immune competence is defined as the ability of the immune system to respond
adequately on an antigenic stimulus by an appropriate immune response with a balance between
tolerance and inflammation.
2.1 Functional feed components
The immuno modulatory effects of specific feed ingredients is assumed to be related to some
functional components in  these feed matrices. The mode of action of these components, however, is
often unknown.
Integration of “omics” techniques like gene-expression profiles (micro-arrays), proteomics, and
metabolomics, could fill in this gap of knowledge. The data gained with these techniques would
significantly contribute to the elucidation of the mechanisms how specific components and/or
ingredients in feed positively influence functional processes in the GI tract, and with this, the overall
performance of farm animals.
Combined information about gene-chemical associations retrieved from on-line available databases
can be used to predict the in-vivo biological activity of natural occurring chemical compounds, i.e.
predict their “defined mode of action”. Or contrariwise, this information can be used to find
compounds that have potential to influence the function of specific genes/proteins or biological
processes. Such a data-mining approach has already accelerates the development of alternative or
new dedicated supplements/ additives for human foods. In chapter 2, an overview of gene-expression
datasets of feed-related studies in farm animals posted in two databases will be discussed. Secondly,
a tutorial is provided how to explore all information in these databases in order to (in-silico) predict
chemical compounds and additives that have potential to steer the expression and function of specific
genes/processes in the GI tract of farm animals.
2.2 Animal models available for studying immune
competence
In vivo experiments are widely used to investigate the effects of nutritional interventions on immune
related parameters in animals. In these studies animals are used as goal animals, or as a model for
humans. In vivo experiments, however, might increase the level of discomfort of the animals, are time
and labour intensive, and costly. For some research questions, other types of experiments can be used
as well, thereby lowering the level of disadvantages compared to in vivo experiments. Chapter 3
describes the characteristics, applications and benefits of different types of in situ, ex vivo, in vitro as
well as in vivo models that can be used to investigate immuno modulating research questions.
2.3 Nutritional immune modulation
Infectious diseases greatly impair animal welfare and efficiency of nutrient use and thus the
environmental footprint of animal production [1]. Appropriate nutrition becomes even more critical as
anti-bacterials, anti-parasitics and other additives that promote animal health are eliminated due to
consumer demands. Nutrition may aid in minimising the incidence of diseases by enhancing immunity.
It can be questioned, however, whether the diets in use today for realizing maximal production
efficiency are sufficient for optimal immunity. Klasing [1] distinguished six different mechanisms by
which diet might affect immunity: 1) feeding the cells of the immune system, 2) feeding pathogens, 3)
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modifying the responses of leukocytes, 4) protecting against immunopathology, 5) influencing the
microbial ecology of the gut, and 6) stimulating the immune system.
Growing evidence highlights the importance of a mother's nutrition from preconception through
lactation in programming the developing immune system of her offspring [2]. Examples of nutrition-
mediated immune programming can be found in the literature on intra-uterine growth retardation,
maternal micronutrient deficiencies, and infant feeding. One programming mechanism involves
activation of the maternal hypothalamic-pituitary-adrenal axis in response to nutritional stress.
Maternal malnutrition may also have a direct influence, as evidenced by nutrient-driven epigenetic
changes to developing T regulatory cells and subsequent risk of allergy or asthma. A third
programming pathway involves placental or breast milk transfer of maternal immune factors with
immuno modulatory functions (e.g. cytokines). Early immune system programming can give rise to
changes in the foetal immune system that can persist over the life course [3]. An inappropriate
maternal immune activation may contribute to an increased risk in the offspring of
neurodevelopmental disorders, auto immune diseases and allergies later in life, but well-controlled
maternal immune responses might play a positive physiological role in foetal immune and nervous
system development [3]. The foetal immune system is particularly vulnerable to environmental insults
(e.g., malnutrition, toxins, infections, and stress). Therefore, adequate maternal/foetal nutrition is
necessary to stimulate the appropriate development of foetal and neonatal immune responses and
immune cell proliferation, placentation, and the development of oral tolerance. According to Korver [4]
nutritional immunomodulation holds great promise as a means to increase poultry productivity and
health. The induced changes in immune function, however, may predispose the animals to other
diseases, or decrease production characteristics.
This study aims, among others, to review the nutritional interventions that directly or indirectly (via
the microbiota) engage the optimal development of the innate and acquired immune system of farm
animals and humans, both in the maternal, neonatal and post-neonatal phase. This The results of this
literature search are described in chapter 4.
2.4 Relation between immune system of the gut and
airways
Farm animals may be vulnerable to respiratory diseases. The upper airways are protected by a
mucosal immune system that is partly connected to other mucosa of the body. Together this mucosal
immune system is referred to as the “common mucosal immune system”. The primary specific defence
at this mucosa is formed by IgA antibodies. A hypothesis on the common mucosal immune system
suggested that antigenic stimulation at any inductive site of the mucosal immune system results in a
specific immune response characterized by IgA antibody production in other mucosa included in this
system. Therefore, nutritional interventions may not only affect the immune system in the gut, but
simultaneously the immune system of the upper airways. This question is discussed in chapter 5.
Livestock Research Report 800 | 25
3 Feed ingredients and functional
components
The need of efficacious, safe and low-cost feed additives displaying a defined mode of action urges the
animal production industry to invest more money in more specialized research to discover such new
additives. Still most in-vivo feed-intervention studies performed in farm animals today measure
conventional “performance” parameters" (e.g. feed and water intake, growth, resistance to infection,
general health status). Although these parameters are essential data for the feed industry, they do not
provide detailed insight in how functional components in feed-formulations interact with the animal.
Integration of “omics” data like gene-expression profiles (micro-arrays), proteomics, and
metabolomics, could fill in this gap of knowledge. The data gained with these techniques would
significantly contribute to the elucidation of the mechanisms how specific components and/or
ingredients in feed positively influence functional processes in the GI tract, and with this, the overall
performance of farm animals.
The last two decades a large number of gene-expression datasets describing nutritional intervention
studies in the intestines of rats and mice, and in cultured intestinal cells (human and animal) were
posted in the Gene Expression databases (GEO-NCBI and ArrayExpress-EMBL). Together with data
from conventional biological and immunological in-vitro and ex-vivo experiments, these expression
data of genes are linked to interacting chemical compounds in databases like the Comparative
Toxicogenomics Database (CTD) and PubChem (NCBI), and interactive web-based resources like
STITCH. The power of these databases lies in their comprehensive interconnectivity to other biological
and chemical data-resources. Public and commercial resources that store information about gene
function (e.g. NCBI-Entrez Gene and Genecards: including Gene Ontology terms), transcriptional
regulation (e.g. GNCpro), expression in specific cell-types/tissues (BioGPS), (genetic) diseases (e.g.
NCBI OMIN), specific biological processes and pathways (e.g. KEGG, DAVID), enzyme activity and
metabolism (e.g. Brenda), and relevant literature (PubMed). Combined information about gene-
chemical associations retrieved from all these databases can be used to predict the in-vivo biological
activity of natural occurring chemical compounds, i.e. predict their “defined mode of action”. Or
contrariwise, to find compounds that have potential to influence the function of specific genes/proteins
or biological processes. Such a data-mining approach has already accelerates the development of
alternative or new dedicated supplements/additives for human foods
(http://www.ncbi.nlm.nih.gov/pubmed/20233651/ http://www.ncbi.nlm.nih.gov/pubmed/17506913).
For farm animals the majority of gene expression profiles recorded in the GI track and posted in GEO
and ArrayExpress, were obtained after a challenge with enteric pathogens, mainly bacteria. So far only
a dozen gene-expression datasets were posted in GEO and ArrayExpress in which nutritional
interventions in the GI tract of farm animals was studied without, or in combination with a challenge
with enteric pathogens. Unfortunately, not all these datasets are linked to a scientific paper that
summarizes and discusses the outcome of these data. This makes these data less accessible for
researches not skilled in analysing gene-expression data. This backlog in available “omics” data
compared to human, mouse and rat, does not necessary has to be a limitation to apply data-mining
strategies also for farm animal feed-research. A clear advantage compared to a decade ago is the
completion of the sequence of the cattle, pig, chicken and sheep genomes. Comparison of these
genomes to the more in detail characterized human and mouse genomes has accelerated gene-
annotation and identification of regulatory elements in farm animal genomes, making extrapolation of
human, mouse and rat gene expression data to farm animals more reliable.
In the first part of this paragraph an overview of gene-expression datasets of feed-related studies in
farm animals posted in GEO and/or ArrayExpress will be discussed. In the second part of this
paragraph a tutorial is provided how to explore all information in the above mentioned databases in
order to (in-silico) predict chemical compounds and additives that have potential to steer the
expression and function of specific genes/processes in the GI tract of farm animals.
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3.1 Gene expression datasets of nutritional interventions
in farm animals
A total of 2, 11, and 12 gene expression datasets of feed-intervention studies performed in cattle,
pigs, and chicken, respectively, were posted in GEO and ArrayExpress. In all these studies changes in
gene-expression were measured in different parts of the GI track as well as in cultured gut-derived
ex-vivo cells or cell-lines derived from gut tissues. In Appendix 1, 2, and 3 an overview of these
intervention studies is listed (marked with p1, b1, or c1 etc.), including a brief description of the
experimental design and the most important genes and/or processes found regulated. Intervention
studies with bacterial endotoxins, LPS and probiotic bacteria were also included in this overview. If
available a PubMed web link of the peer-reviewed scientific publications describing the results of these
intervention studies is provided in Appendix 1,2, and 3..
Compared to the dozens of gene-expression studies conducted with tissues collected from udders
and/or mammary glands of dairy cows, so far only two gene expression datasets were posted in which
gene expression was measured in tissue collected from the GI tract of cattle (b1, b2). Both datasets
describe changes in gene expression recorded after imposing sub-acute ruminal acidosis by feeding
dairy cows with dietary grain or high and low concentrate grain diets (HC). In both these studies
genes involved in maintenance of the integrity of the ruminal epithelial layer were found to be
regulated.
Most intervention studies, in which gene expression profiles were recorded in the gut of pigs and
chickens, were aimed to find alternatives for antibiotic treatment against enteric pathogens. Four gene
expression datasets were recorded from intestinal lymphocytes (IEL’s) isolated from chickens fed with
a diet supplemented with chemicals and/or phytogenic compounds/extracts (anethol [c4], secondary
metabolites of garlic [c7], and plant extracts of C. annuum fruits [c12] and Curcuma longa [c6]), all
four intended to reduce the negative impact of coccidiosis (Eimeria infection) on overall performance
of chickens. Gene expression was measured in the jejunum of chicken fed with mannose-rich
oligosaccharides (isolated from Saccharomyces) in order to compare this additive to treatment with
the antibiotic virginiamycin (c8). In addition, gene expression experiments were conducted in which
the effect of toxins produced by enteric pathogens on gene expression in intestinal cells was studied.
In-vitro cultured chicken intestinal macrophages (HD11 cell-line; c9) and pig jejunal segments in (in-
situ SISP model; see above) were challenged with endotoxins from Salmonella and ETEC (p3),
respectively. The genes responding in these studies provided valuable information about the innate
immune mechanisms activated by bacterial endotoxins. Challenge of cultured “Intestinal Porcine
Epithelial Cells” (IPEC‑J2) with the fungal toxin deoxynivalenol (DON), a contaminant present in farm
animal diets produced of grains, influenced expression of genes involved in maintenance of the
integrity of the epithelial layer (p5). With respect to the integrity and the barrier function of the
intestinal epithelial layer, several gene expression studies have been conducted in a pig model
developed to study induction of necrotizing enterocolitis (NEC) in human preterm neonates (p3, p8,
p9). NEC is often induced in preterm neonates when formula milk is provided using enteral tubes.
Feeding of formula milk to preterm piglets was compared to colostrum, and gene expression was
measured in the distal small intestine of preterm pigs fed by an enteral tube or orally. Gene
expression profiles in these studies showed that enteral tube feeding with formula milk induces a pro-
inflammatory insult to the immature intestine of the preterm pigs, resulting in development of NEC.
Amniotic fluid (AF) added as additive to formula milk suppressed this inflammatory insult, and it was
suggested that components in AF reduced the pathogenesis of NEC (p9). The studies reported above
were primarily performed in pigs and poultry, and extrapolation to other species therefore should be
administered with caution.
In experiments conducted to relate feed efficiency and daily gain of chickens to their diet, 2 studies
used gene expression profiles to investigate the metabolic mechanisms of feed conversion and uptake
in the gut. Expression profiles recorded in the jejunum after feeding with organic or conventionally
produced starter and grower diets were compared in chicken lines with different genetic backgrounds
(c11). In a second study, duodenal expression profiles were compared between groups of chickens
showing different efficiencies in food-to-energy conversion (Apparent Metabolizable Energy [c1]).
Direct-fed microbials (DFM) have been shown to increase overall performance of daily farm animals.
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In one pig (p6), and two chicken studies (c1, c10) gene expression profiles were recorded in the
intestine after repeated oral administration with cultures of probiotic bacteria. The expression profiles
recorded in the pig study (p6) clearly indicated that repeated oral administration with Lactobacillus
plantarum 299v had a beneficial effect on the mucosal innate and adaptive immune system. Briefly,
genes involved in the intestinal immune network for IgA production were regulated by Lactobacillus
plantarum 299v, especially in the ileum.
3.2 Functional analysis and data-mining using a gene
expression dataset
As depicted in Figure 13 (Chapter 5), chemokine’s CCL25 and CCL28 initiate the attraction, migration
and homing of (pre)-IgA Ab-secreting cells (ASCs) from the GALT to effector sites in the lamina propia
of the small intestine and colon, and to other mucosal effector sites in the body [5]. Gene expression
of CCL25, and of the pre-B cell surface markers CR2 (complement component receptor 2) and MME
(membrane metallo-endopeptidase) was up-regulated more than 10 times in the colon of pigs after
repeated oral administration with Lactobacillus plantarum 299v preparations (dataset p6 in Appendix
2a). This led to the hypothesis that infiltration of the colon with activated pIgA+ precursor cells or IgA
Ab-secreting cells (ASCs), likely, originating from ileum GALT (e.g. Peyers patches) may have
occurred. We used this set of 122 regulated genes as input list in web-based bioinformatics programs
and retrieved relevant biological and chemical information from databases in order to predict a set of
“candidate” feed-additives which could induce similar processes in the colon of pigs as Lactobacillus
plantarum 299v did. The bioinformatics analysis of the gene expression dataset recorded in the ileum
of this pig study will be presented elsewhere (Hulst et. al., submitted 2014).
In Appendix 4 a point to point tutorial is given to perform such a data-mining strategy. Two sub-lists
of genes were extracted from bioinformatics programs DAVID and GeneDecks; 1 representing genes
involved in “small molecule metabolic processes” (SMMP list; Appendix 5) and 1 list of genes involved
in “immune processes” (“immune phenotype”), cell-adhesion, and cytoskeletal rearrangements (IAC
list; Appendix 6). These lists were separately analysed in DAVID and GeneDecks to i) retrieve relevant
pathways/processes, ii) identify the most frequently present transcription factor binding sequence
(TFBS) within the loci of the regulated genes, iii) predict which type of cell or tissue supports
expression of the majority of the regulated genes, and iiii) to find significant associations of the
regulated with relevant chemicals. In supplementary Appendix 7 and 8 the results of these
bioinformatics analysis are presented for the SMMP list and IAC list, respectively. In addition, to
identify functional associations and crosstalk between proteins encoded by differential expressed
genes and relevant chemicals, a combined list of SMMP and IAC genes was uploaded in the (protein)-
protein-chemical interaction web tool STITCH 3.1 beta. An interactive network was built from 18 genes
and 4 chemicals (Figure 1) which all scored associations with a high level of confidence (≥0.7; see
Appendix 9). By clicking on the lines which connects two nodes (genes or chemicals), relevant
literature and information about the type of association (e.g. a physical interaction, or an enzyme-
substrate relation, etc.) can be accessed directly in other biological and chemical data-resources
(note; only interactive on-line). Four key-genes, displaying a central role in this network (APOC3,
NR1H4, CYP3A4, and CYP4F3), were selected together with 3 genes mapped to the “B Cell Receptor
Signaling Pathway” (CR2, APOC3, and SPP1; highlighted in red in Appendix 8). The latter 3 genes
were selected based on the “pIgA+ precursor cell” hypothesis (see above), the prediction that a
majority of genes from the IAC list can be expressed by “lymphomaburkitts” cells (B lymphoma cel
line), and their gene loci contains a TFBS of the transcription factor T (BRACH; Brachyury Homolog
Mouse), a transcription factor highly active in B-lymphocytes (highlighted in red in Appendix 8).
CYP4F3A catalyses the omega-hydroxylation of leukotrine B4, a potent chemoattractant for
polymorphonuclear leukocytes. NR1H4 (alias Farnesoid-X-receptor or ileal bile acid transporter) is a
bile acid-activated transcription factor which regulates the expression of genes involved in bile acid
synthesis and transport. CYP3A4 is a monooxygenase involved in linoleic acid, steroid, and retinol
metabolism. With respect to retinol metabolism, 4 remarkable genes were up-regulated. APOA1,
APOA4, APOB, and RBP2, all mapped to the KEGG “Vitamin digestion and absorption” pathway
(hsa04977).The proteins encoded by these genes are components of the chylomicrons-mediated
exocytosis mechanism, a mechanism by which enterocytes secrete luminal absorbed fat-soluble
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vitamins, retinol, and cholesterol esters into the lymphatic system (highlighted in blue in Appendix 7
and 8). APOC3 inhibits the uptake of lymph chylomicrons by cells. According to the literature retrieved
from the STITCH network NR1H4 influences gene expression and function of APOC3
(http://www.ncbi.nlm.nih.gov/pubmed/22187655).
The Comparative Toxicogenomics Database (CTD) was explored to find chemicals having potential to
influence the expression and/or the function of these seven selected key-genes. In Appendix 10, for
each key-gene 3 chemicals with potential were listed (web links provide direct access to literature
describing the association between a gene and a chemical). The NR1H4 appeared as a central
gene/protein in the STITCH network. In addition to the predicted role of NR1H4 in regulation of the
transport of fat-soluble vitamins (see above), this nuclear receptor also plays a role in regulating gene
expression in intestinal immune cells (see literature links in Appendix 10). Chemicals like alpha-
Linolenic Acid and Epigallocatechingallate (EGCG; a natural phenol with antioxidant properties found in
high concentrations in green tea), may therefore be promising “candidate additives” to steer gene
expression of NR1H4, and with this, immune processes in the intestine. In addition, EGCG also
modulates gene expression of NCK1, a key coordinator of cytoskeletal changes in various types of
immune cells (including B-cells), enabling polarization and directional migration of these cells. At first,
such “candidate” additives have to be tested in an in-vitro test. Preferably, a test capable of
measuring parameters reflecting the mechanisms predicted by the here performed data-mining
strategy. In case of the Lactobacillus plantarum 299v dataset analyzed here, for example, mixed
cultures of enterocyte cell lines and ex-vivo IEL’s and/or B cell fractions may be challenged with these
chemicals, and tested for expression level of the 3 key-genes CR2, APOC3, and SPP1, or other genes
from the IAC list by quantitative real-time PCR. If the outcomes of such experiments are in agreement
with the processes predicted by data-mining, an in-vivo intervention study, specifically designed for
one chemical or a group of related chemicals, may prove whether the “candidate” additives or their
analogs can replace DFM like Lactobacillus plantarum 299v as an feed-additive that initiates the
attraction, migration and homing of (pre)-IgA Ab-secreting cells.
Livestock Research Report 800 | 29
Figure 1 Interactions between genes/proteins regulated in the colon of pigs in response to repeated
L. plantarum administration and relevant chemicals.  The displayed network was generated
using the (protein)-protein-chemical interaction web tool STITCH 3.1 beta (see also
Appendix 9; http://www.ncbi.nlm.nih.gov/pubmed/19897548).
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4 Human and animal models for testing
immune competence
The intestine is at the same time the place for nutrient uptake and the barrier against pathogenic
antigens. A direct consequence of these physiological functions is a very complex interplay of different
cell types leading to a tightly controlled mucosal immune balance in the healthy gut [6].
Using several animal models, intestinal mucosal immunology has been studied in vivo (Latin for
"within the living")[7] mostly in relationship with pathological conditions, such as inflammatory bowel
diseases (Crohn's disease and ulcerative colitis)[8]. As a consequence of, among others, the
protection of animals used for scientific purposes and the 3R (reduction, refinement and replacement)
approach in animal experimentation, intestinal ex vivo models have been developed and employed. Ex
vivo (Latin for "out of the living") refers to experiments done in or on tissue in an artificial
environment outside the organism with the minimum alteration of natural conditions, allowing
experimentation under more controlled conditions than possible in in vivo experiments, at the expense
of altering the "natural" environment [7]. Driven by the ask for faster and cheaper systems, besides
pathology related models, intestinal in situ, ex vivo and in vitro models have also been used in
research on absorption [9], bacteria-host interactions [10-13] and food science and nutrition [14-17].
In vitro (Latin: in glass) models are those that are conducted using components of an organism that
have been isolated from their usual biological surroundings in order to permit a more detailed or more
convenient analysis than can be done with whole organisms, and are also known as “test tube
experiments” or “petri dish experiments” [7]. In situ (Latin: in position) models are intermediate
between in vivo or ex vivo and in vitro models. For example, examining cells within a whole organ
intact and under perfusion may be an in situ investigation. This is not in vivo as the donor is sacrificed
by the experimentation, but it is not the same as working with the cells alone, a common scenario for
in vitro experiments [7].
Although not all of the latter models have been used to study intestinal immunology, they may be
employed for such an immunological driven approach. In this chapter these models are described,
disregarding in silico modelling (modelling performed on a computer or via computer simulation)[18].
4.1 In vitro models
The intestinal wall is composed of several cell types forming the epithelial barrier (mainly enterocytes)
and immune cells on the basolateral side [11, 15]. A perfect in vitro cell model has to be a direct
substitute of the in vivo environment, reflecting both the natural responses as well as the complex
physiology of the intestine. Therefore, cell lines involved in single or co-culture models need to be
sufficiently characterized. Such a characterization includes epithelial markers (cytokeratins), brush
border (digestive) enzymes, expression of tight junction proteins for the formation of epithelial barrier,
integrity and polarity (ZO-1, occludins and claudins, transepithelial resistance (TEER)/transepithelial
electrical potential (TEEP) when grown on a microporous membrane, molecular transporters, internal
metabolism (cytochromes P450-CYPs) and responsiveness to environmental factors like cytokines and
inflammatory molecules (lipopolysaccharides (LPS), cytokines). Depending on the model, cells in
different activation/differentiation state can be used. For example, immature non-activated immune
cells are useful in host-bacterial intestinal interaction models, while activated cells can be used to
study inflammatory intestinal disorders.
4.1.1 Primary cells
Primary cells, isolated from (human or animal) tissue, retain the majority of in vivo functionality [11,
15]. They are however rarely used as their survivability is limited and usually need to be derived from
different individuals in subsequent tests affecting the reproducibility of the results.
On the other hand, recently commercial sources of primary human intestinal epithelial cells (hlnEpCs)
have become available [19].
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4.1.2 Epithelial mini-guts
However, recently an in vitro culture system to grow three-dimensional (3D) intestinal epithelial
organoids (‘epithelial mini-guts’) for periods greater than 1.5 year from Lgr5+-CBC cells has been
established [20]. Slender crypt base columnar (CBC) cells are present at the crypt bottom,
intercalated between post-mitotic Paneth cells. Lgr5+ marked CBC cells persist for the life-time of a
mouse, whereas their progeny include all differential cell lineages of the epithelium. Lgr5+-CBC cells
represent cycling, long-lived, multipotent stem cells. Isolated crypts require Matrigel, a 3D laminin and
collagen-rich matrix that mimics the basal lamina and a cocktail of R-spondin (a protein interacting
with Wnt that constitutes the key pathway to maintain stem cell fate and drive proliferation),
epidermal growth factor (EGF) and the polypeptide Noggin is the minimal essential stem cell
maintenance cocktail. In vitro-generated organoids occur as cysts with a central lumen flanked by a
simple, highly polarized villus epithelium. The basal side of the cells is orientated toward the outside,
touching the matrigel, whereas enterocyte brush borders form the luminal surface. Secretion by
Paneth and goblet cells occurs toward the lumen. The organoids can be passaged weekly for at least
1.5 years with a phenotype and karyotype that reamin unchanged. To test how normal the epithelial
mini-guts are, they were introduced per anum into the colons of mice with chemical-induced mucosal
lesions. The engrafted epithelial mini-guts regenerated epithelial patches that were indiscernible from
surrounding recipient epithelium and persisted for at least 6 months without changing their
histological appearance.
4.1.3 Cell cultures
Most currently used intestinal cell line models are transformed cell lines isolated from cancer affected
individuals [21, 22]. Among them, Caco-2 is the most widely used and established cell line. Caco-2
(colon adenocarcinoma) were isolated from a 72-year old Caucasian man and upon reaching
confluence, cells were found to express characteristics of enterocyte differentiation and functionality.
Another human colon adenocarcinoma cell line, HT-29, was isolated from the colon tumour of a 44-
year old Caucasian female, while the Intestine-407 cell line has been established via HeLa cell
contamination and CaSki cells were originally isolated from a metastasis in the small intestine. The
HIEC-6 cell line was established from normal human crypt small intestinal cells. The H4 cell line was
established from human foetal small intestinal cells and subcloned to obtain a small intestinal
epithelial cell line, capable of TEER and TEEP formation.
The most widely used rodent lines are IEC-6 and IEC-18 cell lines derived from the rat small intestine
[21, 22]. The IPEC-J2 cell line is a non-transformed intestinal cell line derived from jejunal epithelia
isolated from a neonatal piglet, maintained as a continuous culture and subcloned to obtain cultures of
enterocyte-like and mucin producing cell types.
4.1.4 2D Cell cultures
Cells are mostly cultivated as one-dimensional monolayers on plastic surfaces, where the
establishment of a functional, epithelial character is not achieved, possibly resulting in misleading
results, especially in adhesion assays [11, 15].
Growing cells on microporous membranes (e.g. insert filters, Transwell models) results in spontaneous
cell differentiation and polarization, enabling basolateral feeding of epithelia similar to the in vivo
setting and facilitating transport studies through the polarised epithelial monolayer [11, 15].
Semi-wet interface culture in combination with mechanical stimulation and DAPT causes HT29, MTX-
P8, MTX-E12 and LS513 cells to polarize, form functional tight junctions, form a three-dimensional
architecture resembling colonic crypts and produce an adherent mucus layer [23]. Caco-2 and T84
cells also polarize, form functional tight junctions and produce a thin adherent mucus layer after such
a treatment, but this is less consistent.
Newly commercially available primary human intestinal epithelial cells (hlnEpCs) and induced
pluripotent stem cell (iPSC)-derived intestinal cells in Transwell inserts may become an alternative
source of human intestinal cells [19].
Epithelial cells growing on microporous membranes can be co-cultured with monocyte/macrophages
(derived from the same species) in the lower compartment or on the microporous membrane using an
inverted setting [15, 24]. In this way the in vivo environment of the intestine is better stimulated and
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the chemical crosstalk (chemokine and cytokine release) between intestinal and immune cells (in
response to an antigenic stimulus) can be studied. Epithelial cells can also be co-cultured with other
more-specialized cell types on microphorous membranes, like mucus-producing Goblet cells.
4.1.5 3D Cell cultures
3D cell models are built from intestinal epithelail cell line growing on a microporous membrane,
enabling polarisation of the cells and development of TEER/TEEP [15, 24, 25]. Below the microsporous
membrane (basolateral side) epithelial cells are underlaid with immune cells (macrophages, dendritic
cells), mimicking mucosal lymphoid tissue (Figure 2).
The pig intestinal cell model is a co-culture composed of the CLAB (adult mucin secreting enterocyte-
like) or PSI (partially differentiated cryptic enterocyte-like) intestinal lines and of the PoM
monocytes/macrophages that can be differentiated into dendritic cells [15, 24].
Bovine, ovine and goat 3D intestinal cell models are for bovine a co-culture of CIAB (calf intestinal
epithelial cells) and BOMA (bovine macrophages), for ovine a co-culture of OSI (ovine small intestinal
cells) and MOLT-4 (monocyte/macrophage cell line) and for goat a co-culture of GIE (goat intestinal
epithelial cells) and GOMA (goat macrophages) [24].
Figure 2 Setup of the co-culture consisting of intestinal epithelial cell line, macrophages and
dendritic cells (from Leonard et al., 2010 without permission)
4.1.6 Intestine-on-a-chip
3D Cell cultures yield levels of cell differentiation and tissue organization that are not possible in 2D
cultures. New advances in 3D culture that leverage microfabrication technologies from the microchip
industry and microfluidics approaches to create cell culture micrenvironments that support tissue
differentiation are being developed [26-28].
The intestine-on-a-chip recapitulates multiple dynamic physical and functional features of the human
intestine that are critical for its function within a controlled microfluidic environment for transport,
absorption and toxicity studies, and therefore should have great value for drug testing as well as
development of novel intestinal disease models [29]. The biomimetic ‘human intestine-on-a-chip’
microdevice is composed of two microfluidic channels separated by a porous flexible membrane coated
with extracellular matrix (ECM) and lined by human intestinal epithelial (Caco-2) cells (Figure 3). The
gut microenvironment is recreated by flowing fluid at a low rate producing low shear stress over the
microchannels and by exerting a cyclic strain that mimics physiological peristaltic motions. Under
these conditions, a columnar epithelium develops that polarizes rapidly, spontaneously grows into
folds that recapitulate the structure of intestinal villi, and forms a high integrity barrier to small
molecules that better mimics whole intestine than cells in cultured in static Transwell models. In
addition, a microbe (Lactobacillus rhamnosus GG) can be successfully co-cultured for extended periods
of more than 1 week on the luminal surface of the cultured epithelium without compromising epithelial
cell viability which actually improves barrier function.
Ultimately, the development of organ-on-a-chip systems will converge into multi-organ body-on-a-
chip systems composed of functional tissues that reproduce the dynamics of the whole-body response
[30].
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Figure 3 The human intestine-on-a-chip. (a) A schematic of the intestine-on-a-chip device showing
the flexible porous ECM-coated membrane lined by epithelial cells cross horizontally
through the middle of the central microchannel and full height vacuum chambers on both
sides. (b) A photographic image of the intestine -on-a-chip device composed of clear PDMS
elastomer. A syringe pump was used to perfuse (direction indicated by arrows) blue and
red dyes through tubing to the upper and lower microchannels, respectively, to visualize
these channels. (c) A cross-sectional view of the top and bottom channels (both 150 mm
high) of the intestine-on-a-chip; square inset shows a top view of a portion of the porous
membrane (10 mm pores; bar, 20 mm). (d) Schematics (top) and phase contrast images
(bottom) of intestinal monolayers cultured within the intestine-on-a-chip in the absence
(left) or presence (right) of mechanical strain (30%; arrow indicated direction) exerted by
applying suction to the vacuum chambers. Red and blue outlines indicate the shape of a
single Caco-2 cell before (red) and after (blue) mechanical strain application (bar, 20 mm).
Note that the cell distorts in the direction of the applied tension. The regular array of small
white circles are pores visible beneath the epithelial monolayer. (e) Quantitation of the
mechanical strain produced in the ECM-coated, flexible, porous PDMS membrane (open
circles) and in the adherent epithelial cells (closed circles) as a function of pressure applied
by the vacuum controller (From Kim et al., 2012 without permission)
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4.2 Ex vivo models
4.2.1 Perfusion system
Intestinal fragments or whole organs (rat small bowel, canine colon) are connected with a perfusion
circuit: inflow through cannula connected to the main artery inflow and outflow via the main vein [13].
Perfusion via a perfusion circuit under physiological conditions of either whole organs or resected
intestinal tissue maintains intestinal explants viability (morphology, histology and physiology) up to
several hours of perfusion. The limited duration of an experiment and the need for sufficient quality
and quantity of organs are a major disadvantage of such a system.
4.2.2 Everted sac technique
The intestine is divided into segments of 5-6 cm each and each segment is washed with an ice-cold
physiological solution [31]. The washed intestinal segment is gently everted over a glass rod. One end
of the everted segment is tied off and filled with Krebs solution of 37oC after which the filled intestinal
everted segment is sealed with a second tie. The filled everted sac is transferred in an incubation flask
with oxygenated medium at 37oC.
The everted sac model is sensitive and specific with several factors having an impact on the results of
transport studies, including animal factors (species, age, sex, diet, disease state, chronic treatment,
harvesting time, method of killing), intestinal segment used (duodenum, jejunum, ileum, colon) and
experimental conditions (e.g. pH, aeration, temperature). The tissue viability and metabolic activity is
approximately 2 hours and is one of the limiting disadvantages of this technique.
4.2.3 Ussing chamber
Ussing chambers are mostly used for the characterization of intestinal absorption in different parts of
the intestine [32].
Intestinal tissue (from all intestinal segments) is collected in ice-cold Krebs-Ringer bicarbonate (KRB)
buffer supplemented with NaHCO3, CaCl2 and HEPES adjusted to pH 7.4 [32]. The adipose tissue and
muscle layers are carefully removed and the mucosa is mounted in the Ussing chamber (with an
exposed tissue area of 0.46 cm2. Both compartments of the Ussing chamber are filled with pre-
warmed KRB-buffer and continuously oxygenated with 95% O2 and 5% CO2 gas mixture and
maintained at 37oC. The viability of the mounted mucosa is assessed by monitoring the transepithelial
potential difference (PD) which remains stable for at least 90 min.
4.2.4 In vitro organ culture (IVOC)
Although called in vitro organ culture (IVOC), the different forms of IVOC are also described by the
term ex vivo organ culture [12]. The latter term better approaches reality, as in IVOC survival time of
biopsies is limited -notwithstanding the  oxygenation of the tissue to achieve adequate exchange of
gas and nutrients- and fresh organ tissue is needed for each new experiment [12].
The major advantage of such organ cultures is the anatomical resemblance of the in vivo situation
[13]. Other advantages of such organ cultures are the use of tissues from different parts of the
intestine (from duodenum to colon), from various species representing specific microbiota, genetic
and/or disease backgrounds and from animals or humans, which have been subjected in vivo to food
ingredients [13].
The careful and laborious preparation, relatively low-throughput and short term survival in culture –
which may be extended with advanced knowledge in tissue engineering- are the major disadvantages
of such organ cultures [13].
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4.2.5 Non-polarized (or traditional) IVOC
Intestinal biopsies (obtained from patients receiving upper endoscopy, ileo-colonoscopy or surgical
intestinal resection) are placed on a thick supporting sponge or agarose gel base (with the apical side
upward and the serosal side downward in direct contact with the underlying sponge) in IVOC medium
to create a thin film of medium on the apical sides of biopsies [12](Figure 4A). Bacterial overnight
cultures are inoculated on the mucosal side of the biopsies and incubated at 37oC on a rocker in an
atmosphere of 95% O2 and 5% CO2 with regular replacement of medium to keep the biopsies viable.
At harvest, the biopsies were removed and shaken in medium to remove mucus and bacteria.
Disadvantages of non/polarized IVOC comprise the inability to apply different conditions to either side
of the biopsies [12]. Furthermore, no interactions with deep tissue, different severity of trauma
caused by biopsy sampling procedure, diverse underlying diseases of the patients and individual
variations in the gut flora associating with the biopsy tissues, are inevitable weaknesses of this model.
Figure 4 Mounting of intestinal biopsies for traditional in vitro organ culture (IVOC) and polarized
IVOC. (A) A biopsy specimen mounted on a sponge or an agarose plug immersed in the
medium with its mucosal surface upward. (B) After orientation of the tissue on a
nitrocellulose filter, the apical disc was fixed to the mucosal side of the biopsy via tissue
glue. The sandwich was then inserted between a Snapwell support (from Fang et al., 2013
without permission)
4.2.6 Polarized in vitro organ culture (pIVOC)
In the pIVOC each biopsy is positioned as a sandwich between two acrylic glass discs with a central
aperture slightly smaller than the size of the biopsy [12](Figure 4B). The upper disc is sealed to the
peripheral area of the mucosal side of the biopsy to minimize leakage from the apical to the basal
compartment. The sandwich holding the biopsy is then mounted in a Snapwell insert. After transfer
into a six/well plate, the explant tissue is submerged in medium and incubated at 37oC on a rocker in
an atmosphere of 95% O2 and 5% CO2 with regular replacement of medium to keep the biopsies
viable. At harvest, the biopsies were removed and shaken in medium to remove mucus and bacteria.
4.2.7 Novel polarized ex vivo organ culture
Samples are excised from the intestines of patients at the time of surgery and directly transferred in
HBSS buffer supplemented with bacteriostatic antibiotics at 4oC to the laboratory [33, 34]. The clean
mucosal layer is washed in Hank's buffer and cut with sterile scalpels into 1 cm2 pieces. The pieces are
placed on sterile metal grids with the basolateral side facing downwards. and the cylinder (cloning
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cylinder) is attached with surgical glue under sterile conditions with a pair of forceps (Figure 5).
Culture medium (Dulbecco's Modified Eagle medium supplemented with foetal bovine serum, non-
essential amino acids, pyruvate, glutamine, epidermal growth factor and insulin) is dispensed in the
centre well of the centre-well organ culture dish and incubation is carried out in 100% O2.
Figure 5 Application of a cylinder on the luminal face of an intestinal mucosal explant does not
impact on tissue wellbeing. (A, B) Schematic representation and photographs of the
technical setting for culture and apical stimulation. (C) Tissue cultured in the absence of
the cylinder (left panel) and with the cylinder (right panel). Ellipse: cylinder contact point.
Scale bars: 500 mm. (D) Left panel: Tissue stained with phalloidin-FITC in the interior of
the cylinder (green) and 49,6-diamidino-2-phenylindole (blue, for nuclear staining) once
the cylinder was removed. Middle panel: The same piece of tissue inside the cylinder
(magnification 43). Right panel: Tissue processed with two cylinders of different size
(magnification 1.53). White lines represent cylinder borders. (From Tsilingiri et al., 2012
without permission)
4.2.8 IVOC in the Ussing chamber
A biopsy or a biopsy sandwiched between two flat discs with a central aperture of 2.5 mm with the
serosal side fixed to the support disc, is inserted into a conventional Ussing chamber [12](Figure 6).
Apical chambers are perfused with anaerobic or low O2 levels on the mucosal side of the biopsy to
stimulate the microaerobic milieu in the gut, whereas basolateral chambers are maintained in
oxygenated conditions to secure good tissue survival. In the IVOC Ussing chamber, temperature and
pH of the epithelial are controlled and transmembrane voltage gradients for perfusion and oxygenation
can be recorded.
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Figure 6 Bacterial infection within in vitro organ culture (IVOC) in the Ussing chamber. An intestinal
explant sandwiched between discs or stretched out by metal pins is mounted between two
half chambers and infected apically with bacteria. The apical and basolateral chambers are
maintained in microaerobic and oxygenated conditions, respectively (from Fang et al.,
2013 without permission)
4.2.9 Precision-cut tissue slices (PCTS)
The small intestine is transferred to ice-cold oxygenated Krebs buffer [35, 36]. Segments of 3 cm are
excised and flushed with ice-cold buffer. One side of the segment is tightly closed, filled with agarose
solution at 37oC and then cooled in ice-cold buffer, allowing the agarose solution to gel. Subsequently,
the filled segment is embedded in 37°C agarose solution using a pre-cooled tissue embedding unit.
After the agarose solution has gelled, precision-cut slices (thickness of 400-450 μm) are cut using a
tissue slicer.
Slices are incubated individually in 6- or 12-well culture plates in RPMI medium. The culture plates are
placed in a pre-warmed cabinet (37°C) in plastic boxes and incubated in an atmosphere of 95% O2
and 5% CO2. Intestinal slices remain viable for 24 h.
PTCS contain all cells of the tissue in their natural environment, leaving intercellular and cell-matrix
interactions intact and are therefore appropriate for studying multicellular processes.
4.2.10 Porcine intestinal tissue model
Intestinal segments of pigs are used in a high throughput system in 24 well culture plates [13].
Intestines of pigs killed after approximately 12 h fasting are excised within 15 min after slaughter and
stored in ice-cold oxygenated (95% O2, 5% CO2) Krebs Ringer bicarbonate buffer adjusted to pH 7.4
(KRB) and transported to the laboratory (time between excision and studies was approximately 45−60
min)[37]. Upon arrival at the laboratory, the intestine was rinsed with KRB and cut open in a
longitudinal direction. With the basolateral side upward, the outer muscle layers are carefully stripped
off. The mucosal tissue is placed on gauze with the apical side upward and circles with a diameter of 8
mm (0.5 cm2) are punched out using with a biopsy punch. The intestinal segments are transferred to
a 24-well plate kept on ice and filled with KRB. Studies are initiated by replacing the buffer with pre-
warmed KRB. The tissues are incubated for 1 h at 37 °C in a humidified incubator at 5% CO2.
This model is further developed to a tractable, medium throughput diffusion chamber based system
InTESTine™ [13].
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4.3 In situ models
4.3.1 Intestinal loop model
In the intestinal loop model, the animal (typically rat, rabbit or mouse) is fasted for approximately 3
days and anaesthetised for the entirety of the surgical procedure [9]. An incision is made in the
midline of the abdomen to expose the small intestine. The desired intestinal segments are sliced, held
with a clamp, and then washed to remove excess food particles while keeping the intestine attached
and in close proximity to the body cavity. The segment is then ligated using suture to form a loop,
assuring normal blood flow and muscle movement to the looped segment. An alternative way to
perform the initial preparation is to make an incision at the desired location and then ligating that end.
To determine particle transport across the intestine, the particle suspension is injected directly into the
loop, and the intestinal loop is returned to the body cavity of the animal for up to 2 h while the
animals are maintained under anaesthesia. After a chosen time period, the animal is sacrificed and the
intestinal loop is removed from the body cavity of the animal. A majority of the time, the closed loop
intestine is returned to the body cavity for 2 h and then the entire intestinal segment is removed.
Another way to use the closed loop method is to inject a solution into the closed loop, remove the
suturing after 2 h, and return the intact intestine to the body, allowing the animal to resume normal
digestive processes and movement. After no more than 24 h, the animal is killed and the intestines
removed for analysis.
4.3.2 Small intestinal segment perfusion (SISP)
After overnight fasting, a piglet is anaesthetized and in the small intestine maximal 10 segments of
approximately 20 cm each are prepared, each with a cranial inflow tube and a caudal outflow tube
[38]. The segments are either paired (in one infected and one non-infected) or not, and perfused for
up to 8 hours with, in the case of paired segments, up to 5 different and, in the case of non-paired
segments, up to 10 different perfusion fluids. For each segment over 8 h net fluid absorption is
determined and from each segment mucosal samples (after 8 hours or at different time points after
the start of perfusion) can be collected to analyse genome responses of  early pathogen-induced
inflammation [39].
4.4 In vivo models
For pathological human conditions, such as Crohn's disease and ulcerative colitis, different animal
models using less complex organisms (roundworm, fruit fly, fish) or rodents (mouse, rat, guinea-pig)
have been developed including spontaneous models, chemically-induced models, genetically
engineered models (transgenic animals), genetically engineered (knockout mice) and T cell transfer
models [6, 8, 40, 41]. In such models blood samples can be taken and by endoscopy or at dissection
intestinal tissue samples. For studying the in vivo functions of human cells and tissues and the human
immune system, ‘humanized' mouse strains have been developed based on immunodeficient mice
with mutations in the interleukin-2 receptor common γ-chain locus [42].
Also in the pig a model for chemically-induced colitis has been described [43-46]. Pigs can be fitted
with catheters allowing frequent blood sampling and intestinal cannulas for taking intestinal biopsies
more frequently than just at dissection [47].
4.5 Correlations between models and real practice in
humans and monogastrics
Advantages and limitations of most models have been indicated. Assessing mucosal immunity [48]
has not been implied in all models described, but in principal from all models tissue and/or fluid
samples can be taken which may be used for immunological analysis.
The correlation between a model and the ‘real practice' of humans or monogastrics, depends on the
(scientific) question to be answered and the model used. Different in vitro, in situ or ex vivo models,
for instance, not always indicate the same:
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- In vitro, Lactobacillus gasseri was found to be effective in reducing Escherichia coli adhesion to Caco-
2 cells, but in ex vivo conditions no exclusion or displacement of Escherichia coli by Lactobacillus
gasseri was observed on jejunal piglet tissue [49].
Furthermore, both studies showing a good correlation and studies showing a bad or no correlation
between a model and the ‘real practice’ of monogastrics have been published. Three examples of both
kind of results, in which the in vitro, in situ or ex vivo experiments are reported in the same source as
the in vivo results, are:
- In vitro, in the human small intestinal epithelial Caco-2 cell model, the supernatants of diets
containing either pre-fermented cereals or their fermentation end-products (short chain fatty acids)
clearly modulated cellular growth, metabolism, differentiation and mucosal integrity [50]. Such effects
were not observed in the same study for in vivo intestinal characteristics (morphology, mitotic
activity) and performance in weanling pigs [50], although in other in vivo experiments positive effects
of fermented wheat have been reported [51].
- In vitro, tempeh, a fermented soya bean, interfered with adhesion of enterotoxigenic Escherichia coli
(ETEC), in situ tempeh reduced ETEC-induced fluid loss in piglet small intestinal segments and in vivo
severity of diarrhoea was less, feed intake increased and daily weight gain increased in ETEC
challenged piglets [52].
- In vitro, a porcine Lactobacillus amylovorus-like strain (pLAI) protected the intestinal permeability of
porcine IPEC-1 cells from the perturbation induced by ETEC and in vivo, in piglets challenged with
ETEC, pLAI increased daily weight gain and tended to increase ETEC shedding and total
immunoglobulin A (IgA) in saliva and serum [53].
Also advancing insight can affect the way models are looked at. In modern biomedical research,
mouse models are often used to explore basic pathophysiological mechanisms, evaluate new
therapeutic approaches and make go or no-go decisions to carry new drug candidates forward into
clinical trials [54]. But while in humans acute inflammatory stresses from different aetiologies result in
highly similar genomic responses, the responses in corresponding mouse models correlate poorly with
the human conditions and also, one another. Among genes changed significantly in humans, the
murine orthologs are close to random in matching their human counterparts, questioning the use of
mouse models to study human inflammatory diseases [54].
A systematic review, focusing on a single question which tries to identify, appraise, select and
synthesize all high quality research evidence relevant to that question, as recently introduced for
animal models [55], may be employed (and may be technically supported by ZonMw).
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5 Nutritional intervention strategies for
monogastrics
This chapter aims to review the nutritional interventions that directly or indirectly (via the microbiota)
engage the optimal development of the innate and acquired immune system, both in the maternal
(par. 4.1), neonatal (par. 4.2) and post-neonatal phase (par. 4.3).
The strategy to search the relevant literature was as follows; the input to the query were 1) general or
specific nutritional factors; 2) immune competence related words, i.e. intestinal/gut health, immune
system, or immunity; 3) species (e.g. pig, Sus scrofa or chicken, broiler, Gallus gallus); 4) ‘maternal’
was used as a key word for searching to studies related to interventions during the maternal stage. It
should be noted that the data presented here are incomplete, however it gives an overview of
literature describing nutritional interventions in neonatal livestock that may affect performance and/or
immune related processes.
5.1 Effects of interventions during the maternal stage on
the immune competence of the progeny
5.1.1 Trans-generational effects
Environmental conditions that are experienced in early life can profoundly influence biology
and long-term health. Early-life nutrition is a well-documented example of such
conditions because they influence the adult risk of developing metabolic diseases. A human Swedish
study showed that diabetes mortality increased in men if the paternal grandfather was exposed to
abundant nutrition during his pre-pubertal growth period, an effect later extended to paternal
grandmother/granddaughter pairs and transmitted in a gender-specific fashion. Poor maternal
nutrition has also been associated with increased risk of type 2 diabetes mellitus over several
generations in North American Indians, and individuals whose grandparents were in utero during the
Dutch Hunger Winter had lower birth weight [56]. The above mentioned examples show that
malnutrition during pregnancy exerts negative effects in the offspring. In this study, however, we are
interested in dietary interventions that particularly improve the immune competence of the progeny.
5.1.2 Trans-generational transfer of immune competence
Below, the mode of action of dietary trans-generational effects on the immune competence of piglets
and broilers is described.
In mammals
According to Salmon et al. [57], immunoglobulins cannot cross the placenta in pregnant sows.
Neonatal pigs are therefore agammaglobulinemic at birth. Therefore, they cannot provide rapid
immune responses at systemic and mucosal sites. Their survival depends directly on the acquisition of
maternal immunity via colostrum and milk. Protection by maternal immunity is mediated by a number
of factors, including specific systemic humoral immunity, involving mostly maternal IgG transferred
from blood to colostrum and typically absorbed within the first 36 h of life. Passive mucosal immunity
involves local humoral immunity, including the production of secretary IgA (slgA) by the mammary
gland (MG), which is transferred principally via milk until weaning. These antibodies are produced in
response to intestinal and respiratory antigens, like pathogens and commensal organisms. Protection
is also mediated by cellular immunity, which is transferred via maternal cells present in mammary
secretions. The hormones addressins and chemokines are involved in the regulation of the cellular
immunity. The enhancement of colostrogenic immunity depends on the stimulation of systemic
immunity, whereas the enhancement of lactogenic immunity depends on appropriate stimulation at
induction sites, an increase in cell trafficking from the gut and upper respiratory tract to the MG and,
possibly, enhanced immunoglobulin production at the effector site and secretion in milk. In addition,
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mammary secretions provide factors other than immunoglobulins that protect the neonate and
regulate the development of mucosal immunity, which is a key element of postnatal adaptation to
environmental antigens [57].
In birds
The egg is the main source of maternal antibodies of broilers. Although maternal antibodies are only
present in broilers during the first 2 wk of life, they may exert a lifelong determinative influence on the
neonatal immune system [58]. Maternal antibodies have strong immuno-regulatory properties which
affect the specific neonatal B and T cell binding repertoire. Maternal antibodies, therefore, can be
considered as non-genetic, information-carrying molecules that transfer knowledge about the
immunologically relevant environment gathered by the mother to her offspring. One of these
antibodies, avidin, was expected to guide the gut microbiota composition [1]. It is bacteriostatic and
inhibits pathogenic bacterial growth. Moreover, parental natural antibodies might be transferred via
the egg shell to the young chicken, thereby preventing the vertical transmission of pathogens. Finally,
evidence for heritability of natural and specific antibody responses was found [59].
5.1.3 Impact of nutritional interventions in the maternal diets on trans-
generational epigenetic effects
It has been demonstrated that maternal dietary interventions could interfere with different parameters
in the offspring, as shown in Table 1. The mode of action, however, differs between intervention
strategies. Addition of the probiotic Saccharomyces cerevisiae to sow diets was found to increase the
IgA concentration in serum of their piglets [60], indicating that this intervention affected the amount
of antibodies. Fish oil supplementation in mice reduced the levels of total OVA-specific antibodies and
OVA-IgG1 titers in the pup blood [61].
Maternal consumption of seaweed extract, fructo oligosaccharides or zinc resulted in increased
cytokine levels in the ileal piglet digesta, in human breast milk, and in 6-month old babies respectively
[62-64], whereas maternal consumption of β-carotene reduced cytokine levels in 6-month old babies.
Dietary supplementation with probiotic (Bacillus cereus var. Toyoi) or with additional vitamins and
trace minerals increased the number of T cells and Leukocytes  in piglets and broilers, respectively
[65, 66]. From a study conducted in rats, it could be concluded that lymphocyte proliferation, which
was impaired at birth after prenatal exposure to a low protein diet, could be overcome in postnatal
rats if 50% or 90% of corn oil in the prenatal diet was replaced by coconut oil [67]. In another rat
study it was shown that a reduced maternal selenium intake of rats reduced the neonatal selenium
status which in turn hampers the neonatal immune system development [68]. Replacing sunflower oil
by fish oil in broiler breeder diets resulted in the offspring in an increased production of leukotriene B5
by thrombocytes, indicating that modulating maternal dietary n-6 and n-3 fatty acid could lead to less
inflammatory-related disorders in poultry [69-71].
Some dietary interventions in the maternal diet (e.g. addition of seaweed extract or vitamins/trace
minerals) resulted in an improved gut integrity of the progeny [63, 65]. Addition of probiotics (e.g.
Bacillus cereus var. Toyoi, Saccharomyces cerevisiae) to sow diets reduced the diarrhea scores of their
piglets [60, 66], whereas maternal zinc supplementation would be an effective way to reduce
diarrhoeal disease in babies [64].
Supplementation of Lactobacillus rhamnosus and Bifidobacterium lactis to pregnant women increased
the adiponectin content of their colostrum [72].
Until now, transcriptomics data is scarce, but addition of addition vitamins/trace minerals to broiler
breeder diets was found to increase the expression of genes that are related to intestinal turnover,
proliferation and development, metabolism and feed absorption in the offspring [73].
The improved immune response of the offspring was not always related to improved performance of
the progeny. Maternal supplementation with seaweed extract, however, resulted in improved body
weight gain of the piglets, and this effect maintained even till the growing finishing phase [63].
Growth depression in broilers that passed through a malabsorption syndrome infection was less if their
mothers received additional vitamins/trace minerals [65]. More details regarding the investigated
studies are provided in appendix 14.
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Table 1 Trans-generational epigenetic effects of dietary interventions in the maternal phase





Giving AKG to sows in late gestation and lactation can improve
the passive immunity transfer to piglets at weaning and at 70 d
of age.
Performance, specific immune parameters, % of
serum bactericidal activity and haemolytic
complement at weaning and 70d of age.
[74]
Corn vs. coconut oil x
protein content
Reduced lymphocyte proliferation at birth of rats after prenatal
exposure to a low protein diet, which could be overcome
postnatally if the prenatal diet included a large amount of
coconut oil and a small amount of corn oil.
Neonatal lymphocyte proliferation in thyme and
spleen; spleen natural killer cell activity.
[67]
Fish oil vs. linseed oil In mice, maternal intake of fish oil but not of linseed oil changes
the offspring’s antigen-specific response.
Fish oil reduced the levels of total OVA-specific
antibodies and
OVA-IgG1 titers in the pup blood, compared to the
control and linseed oil groups.
[61]
Fish oil vs. sunflower
oil
Early access to n-3 PUFA through in ovo reduces pro-
inflammatory cardiac eicosanoid production without affecting
hatchability, and may alter leukotriene production in chicks,
which could lead to less inflammatory-related disorders in
poultry.
Retention of n-3 PUFA in cell membranes, plasma
non-esterified fatty acids, production of pro-
inflammatory eicosanoids, cell-mediated immunity,




Laminarin/Fucoidan SWE supplementation during lactation improved performance
and immune response of weaned piglets.
Performance, pro-inflammatory IL-1a mRNA
expression in the ileum of pigs 11 d after weaning,
increased villi/crypt ratio.
[63]
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Dietary supplementation with live yeast S. cerevisiae to sows
and piglets in the late gestation, suckling, and postweaning
periods can be useful in the reduction of the duration and
severity of postweaning diarrhea caused by ETEC.
Performance parameters, duration of diarrhea,
shedding of pathogenic ETEC bacteria, IgA levels in
serum of piglets.
[60]
FOS A comprehensive analysis of gene expression in human milk
cells to characterise the effect of FOS administration in pregnant
and lactating women on the production of immunoactive agents
in breast milk.
The consumption of FOS by pregnant and lactating





Toyoi supplementation of sows and their piglets had a positive
impact on the health status of the piglets after a challenge with
Salmonella, likely due to an altered immune response.
CD8+ gamma delta T cells in the peripheral blood
and the jejunal epithelium; reduced diarrhea scores;





Probiotic supplementation to pregnant women increased the
colostrum adiponectin concentration, which has anti-
inflammatory properties.




The immune system of broilers can be stimulated by addition of
vitamins and trace minerals to broiler breeder diets, without
affecting the growth potential.
Heamatology, spleen weight, humoral response,
leukocytes, recovery rate of intestinal lesions and




Selenium Maternal selenium intake of rats impacts neonatal selenium
status which in turn influences the neonatal immune system
development.
Selenium content in plasma and milk, neonatal
immune cell differentiation and function.
[68]
Zinc + β-Carotene Addition of zinc to routine iron and folic acid supplements for
pregnant women could be an effective way to reduce diarrhoeal
Zinc supplementation increased interleukin-6
production and β-carotene supplementation reduced
[64]
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disease interferon-g production.
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5.1.4 Conclusions
The most important conclusions were:
 Trans-generational effects of maternal dietary interventions on improvement of gut health and
immune competence has been demonstrated in mammals (mice, rats, pigs, humans) as well as in
poultry.
 The reviewed dietary interventions can be categorized to fatty acids, seaweed extract, pre- and
probiotics, and vitamins and minerals.
 The dietary interventions showed a variety in modes of action. They could affect the composition
of the microbiota, the numbers or activity of specific immune cells, the gut morphology, and the
expression of genes involved in immune response.
 In some studies, it was shown that the maternal dietary interventions resulted in improved animal
performance or reduced incidence of diarrhea of the offspring.
 Only a few studies reported trans-generational effects on gene expression. These studies
investigated the effects of supplemented omega-3 fatty acids or vitamins and minerals.
 Supplementation of maternal diets with specific fatty acids, in particular with fish oil, showed to
have a wide impact on the immune competence of the progeny. Therefore, modulating the dietary
fatty acid profile of maternal diets seems to be the most promising intervention for improving
immune competence of the progeny.
5.2 Impact of nutritional interventions in the neonatal
phase on immune related parameters
5.2.1 Results from literature
Neonatal development is defined as; day 0 to weaning for pigs and day 0 to 14 for broilers, thus the
early development after birth/hatch. Which is hallmarked by the development and differentiation of
the intestine. Morphological, functional and immunological development occur simultaneously, and can
be influenced by the host (genetics), microbiota, environment (feed, antibiotics, etc.). For both pigs
(Table 2) and poultry (Table 3) we have identified a number of macronutrients and micronutrients, as
well as microbiota that influence the performance and/or intestinal immune status of the host.
Macronutrients can be categorized into carbohydrates (sugars / saccharides), fats (vegetable, animal,
etc.), and proteins (polymeric chains of amino acids). Micronutrients are categorized into vitamins
(e.g. A, B, C, and E) and minerals (e.g. zinc, copper, selenium, and iodine). The microbiota is more
difficult to categorize because of the multitude of processes in which they are involved, however
lactobacilli and bifido bacteria are often defined as health promoters. The strategy to search the
relevant literature was as follows; the input to the query were 1) general or specific nutritional factor;
2) immune competence related words, i.e. intestinal/gut health, immune system, or immunity; 3)
species (e.g. pig, Sus scrofa OR chicken, broiler, Gallus gallus OR infants, babies). It should be noted
that the data presented here are incomplete, however it gives an overview of literature describing
nutritional interventions in neonatal livestock that may affect performance and/or immune related
processes.
More details regarding the investigated studies are provided in appendix 12 (pigs) and 13 (poultry).
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Nutritional factors Effect Marker Ref.
Prebiotics Composition gut microbiota was inﬂuenced by piglet diet and age Gas production, pH, microbiota changes, SCFA
production
[87]
All prebiotic supplemented groups had numerically higher Lactobacillus
populations
Weight, intestinal morphology, inflammation
markers, microbiota
[88]
Enhanced structure and function throughout the residual intestine Morphology (Crypt-Villus), epithelial cell proliferation
(PCNA), nutrient transport (ussing chamber)
[89]
Increased (luminal) lactobacilli, lactic acid, and SCFA Morphology, pH, digesta metabolits, microbiota, gene
expression (TNFα, IL-8, IL-1β (C), and IL-10)
[90]
Probiotics Enhanced structure and function throughout the residual intestine Morphology (Crypt-Villus), epithelial cell proliferation
(PCNA), nutrient transport (ussing chamber)
[89]
Effective against E. coli infections in neonatal piglets ileal, colon, cecum, rectal swaps,  lymph node
(specific E. coli test)
[91]




upregulated antioxidant system in serum,
stimulated intestinal development and improved health, leading to better
growth performance, and
decreased proinflammatory and anti-inflammatory cytokine responses
Growth performance, morphology, antioxidant
capacity, Cytokines (IL-1β, TNF-α, IFN-γ, IL-6, TGF-
β, IL-10, IL-4, IL-2, sIL-2R, NF-κB, and SIgA)
[93]
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Table 2 Effects of dietary interventions in the neonatal phase on immune related parameters of pigs
Nutritional factors Effect Marker Ref.
Amino acids
Arginine Decreased intestinal permeability CDK1/cyclin B, PKB/Akt, and AMPK [75]
Less NEC (preterm piglets) Intestinal damage [76]
Promotes growth performance Growth performance, ammonia, amino acids (plasma) [77]
Glutamine /
Glutamate
enhance intestinal function and growth performance O2 consumption by pig enterocytes , glutamine
‘products’
[78]




Zn (ZnO) Both traditionally weaned (> 21 d) and early weaned (< 14 d) pigs
grew faster when fed pharmacological (3,000 ppm) concentrations of
zinc as zinc oxide during at least the 1st 2 wk after weaning.
Growth performance, blood minerals [80]
FE one Fe injection (200 mg) for pigs from sows fed adequate vitamin E





High dosage decreased milk intake, MCT utilized as fuel Blood urea nitrogen, milk intake, glycogen levels tissue [82]
Medium-chain fatty
acids
greater villus height and a lesser crypt depth and greater villus/crypt
ratio depth The intra-epithelial lymphocyte (IEL) counts per 100
enterocytes were significantly decreased





Elevated levels of LC-PUFA enhances acute recovery of ischemia-
injured ileum
Transepithelial electrical resistance (TEER), Flux





Improve the repair of small intestine in previously malnourished
piglets





SCFA butyrate increases epithelial surface area by enhancing
proliferation and inhibiting apoptosis
Villus height, crypt cell proliferation, butyrate [86]
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Nutritional factors Effect Marker Ref.
Prebiotics Composition gut microbiota was inﬂuenced by piglet diet and age Gas production, pH, microbiota changes, SCFA
production
[87]
All prebiotic supplemented groups had numerically higher Lactobacillus
populations
Weight, intestinal morphology, inflammation
markers, microbiota
[88]
Enhanced structure and function throughout the residual intestine Morphology (Crypt-Villus), epithelial cell proliferation
(PCNA), nutrient transport (ussing chamber)
[89]
Increased (luminal) lactobacilli, lactic acid, and SCFA Morphology, pH, digesta metabolits, microbiota, gene
expression (TNFα, IL-8, IL-1β (C), and IL-10)
[90]
Probiotics Enhanced structure and function throughout the residual intestine Morphology (Crypt-Villus), epithelial cell proliferation
(PCNA), nutrient transport (ussing chamber)
[89]
Effective against E. coli infections in neonatal piglets ileal, colon, cecum, rectal swaps,  lymph node
(specific E. coli test)
[91]




upregulated antioxidant system in serum,
stimulated intestinal development and improved health, leading to better
growth performance, and
decreased proinflammatory and anti-inflammatory cytokine responses
Growth performance, morphology, antioxidant
capacity, Cytokines (IL-1β, TNF-α, IFN-γ, IL-6, TGF-
β, IL-10, IL-4, IL-2, sIL-2R, NF-κB, and SIgA)
[93]
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Table 3 Effects of dietary interventions in the neonatal phase on immune related parameters of poultry
Nutritional factors Effect Marker Ref.
Amino acids
Arginine Increasing dietary Arg, but not Lys, from 100 to 120% of the NRC
recommendation increased day 18 BW gain
Body weight gain, feed intake, feed conversion, and
liveability
[94]
treatment differences in growth responses, lymphoid organ
development, and primary antibody titers to SRBC did not occur
Body weight gain, FCR, lymphoid organ weights, and
antibody titres
[94]
-vac birds fed an Arg-deﬁcient diet had lower feed conversion
compared to +vac birds
Vac+ birds had lower day 15 BW than –vac birds, but higher titers to
Newcastle disease virus
Growth, antibody responses, plasma amino acid
concentrations
[94]
Glutamine addition of 4% Gln to the diet or water depressed growth
performance
BW gain, feed efficiency, morphology [95]
Weight gain improved signiﬁcantly in
1% Gln for 21 days. Higher concentrations of bile, intestinal, and
sera IgA, sera IgG and longer intestinal villi
BW gain, feed efficiency, morphology [95]
Threonine Combination of threonine and SC improved growth performance and
intestinal morphology traits in broilers.
antibody titre (Newcastle disease) and cell blood count [96]






Wheat/Soy wheat/rye-based diet compared with a maize-based diet: induces
villus fusion,
a thinner tunica muscularis, T-lymphocyte infiltration, more and
larger goblet cells, more apoptosis of epithelial cells in the mucosa,
shift in microbiota
Body weight, feed intake and FCR, morphology,
microbiota, T-lymphocyte inﬁltration
[98]
Corn/Wheat enzyme supplementation minimized the growth suppression
associated with the C. perfringens challenge, with the most
pronounced effect observed in birds fed the wheat-based diet
BW, FCR, C. perfringens counts [99]
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Nutritional factors Effect Marker Ref.
Fatty acids
Medium-chain triglycerides organic acids and MCA chicks had a better growth performance,
better digestibility, less S. Enteritidis colonization and lower pH in
the crop and intestines.
FOS chicks tended to have decreased Salmonella colonization in
ceca
Performance (weight), microbiota (Salmonella counts),
pH, cecal SCFA
[100]
Poly unsaturated fatty acids n-3 PUFA (SALmate) supplementation altered the intestinal
Lactobacillus species profiles, but did not alter the overall microbial
communities or broiler performance
Performance (weight), microbiota [101]
Short chain fatty acids 0.4% butyric acid was on par with
antibiotic in maintaining body weight gain, and reducing E.
coli numbers and found superior for feed conversion ratio




Prebiotics GOS selectively stimulated the fecal microflora of broiler
chickens
Performance, microbiota [103]
longer jejunal villi, greater specific activities maltase, leucine
aminopeptidase and alkaline phosphatase. Minor improvement in
body weight.
Growth, morphology, uptake of L-tryptophan [104]
β-glucan feed decreases the incidence of SE organ invasion in
neonatal chickens and up-regulating of the functional abilities of
heterophils against an SE
Heterophils,% SE killing, oxidative burst [105]
Probiotics GOS in combination with a B. lactis-based probiotic favoured
intestinal growth of bifidobacteria in broiler chickens.
Performance, microbiota [103]
1.5g/kg Fermacto increased performance of broilers Performance (weight), feed intake and feed conversion [106]
Other
Vitamin E + Se Depletion affects both the maturation of specific lymphocyte
subpopulations and the functional and proliferative capabilities of
the peripheral lymphocytes
CT-1a, CD3, CD4, CD8, sIgs, and Ia [107]
Essential oils (thyme, cinnamon) EO could be considered as a potential natural growth
promoter for poultry at the level of 200 ppm
Growth performance, blood constituents, carcass
characteristics
[108]
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5.2.2 Human
Minerals are essential for a proper development of the neonate and the immune system, examples are
zinc, selenium, copper, manganese, calcium and iron (Table 4). Suppletion of minerals can have a
positive effect on the host, but bear in mind that the (resident) microbiota also make use these
minerals or trace elements for their maintenance. In literature many studies conclude that a deficiency
of minerals lead to impaired immunity, however an excessive dose can be harmful as well. This means
that one must carefully asses what the ‘normal’ range of these minerals is for the host. Addition of
vitamins can have a positive effect on the host’s immune system, as with minerals a depletion is
detrimental for the immune system. Another category are the fatty acids, in literature mainly the long-
chain poly unsaturated fatty acids are described for (young) infants, here two case studies are given.
Pre- and probiotics are often used when infants are given formula, instead of mother’s milk, both pre-
and probiotics try to mimic the mechanism(s) of mother’s milk. Prebiotics are often oligosaccharides,
whereas probiotics are mainly (specific) Lactobacilli and Bifidobacteria. An overview of case studies
describing different nutritional interventions is given in Table 4.
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Table 4 Effects of dietary interventions in the neonatal phase on immune related parameters of human
Nutritional factors Effect Marker Ref.
Vitamins
C + E Not measured Time taken to recover from a very ill status, fever,
tachypnoea, and feeding difficulty; and improvement in
oxidative stress and immune
response indicated by thiobarbituric acid reacting
substances (TBARS) and response to skin antigens.
[109]
LC-PUFA Early diet influences both the presence of specific cell types and
function of infant blood immune cells
formula fed infants had a
higher percentage of CD3+, CD4+CD28+, and lower
percentage of CD14+ cells and produced more TNFα and
INFγ
[110]
Plasma Long-chain polyunsaturated fatty acids (LCP) levels similar to
those of breast fed infants can be achieved with the LCP supplemented
formula used in this trial, without evidence of adverse effects of the LCP
enrichment
Urinary malondialdehyde (MDA), marker for oxidative
stress,  excretion was significantly higher in formula fed
infants. α-tocopherol similar between groups, tendency
for lower values in formula (group F) fed infants
[111]
Prebiotics
scGOS/lcFOS Infants in the intervention group had signiﬁcantly lower incidence of
allergic
manifestations
Epidemiological markers / descriptive statistics [112]
Oligosaccharides Dosage-dependent effect on the growth of Bifidobacteria and
Lactobacilli as well as softer stool
Bifidobacteria/Lactobacilli [113]
Nucleotides supplementation of cow's milk-based formula with NT resulted in a
modest improvement in some antibody responses in our population of
healthy term infants, with no effect on other markers of immune status
and growth




The supplementation of infant formula with B. bifidum and
S. thermophilus can reduce the incidence of acute diarrhoea
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5.2.3 Conclusions
From these different studies it can be concluded that it is possible to modulate the host by a multitude
of nutritional factors. However one must bear in mind that most of the (published) literature is biased
towards publishing (significant) measurable effects on the host. Therefor by definition this overview is
incomplete, nevertheless these studies do show that different nutritional factors affect the host in
different ways. Taken together, no clear biomarker/endomarker can be extracted from this long list of
available studies to investigate the effect on the immune competence of the host. Due to the fact that
in most studies performance (i.e. body weight (gain) and feed conversion rate) is an important marker
to test the impact of the intervention, this is often investigated in conjunction with the morphology of
the small intestine. Nevertheless, in a few studies immunological or microbial parameters were used to
investigate the impact of the intervention, in this way more information is gained of the possible mode
of action associated to immune competence. In other words which genes, proteins and/or microbial
groups that contribute to intestinal immune development and health. From Table 2 it can be extracted
that in terms of immune parameters (e.g. cytokines) prebiotics (and spray dried plasma) could be
potential candidates to further investigate in pigs. For chickens (Table 3), evidence was found in
‘wheat/soy’ diets, ‘Methionine and Cysteine’, as well as ‘vitamin E together with Selenium’, that
showed effects on the immune related parameters (e.g. cytokines, T cells and antibodies). Human
infants were also studied extensively within the context of early life variation and (impact on)
immunity. From these studies we can conclude that one must avoid a depletion of vitamins and/or
minerals in the diet. Furthermore the most abundant nutritional factors were; prebiotics (e.g.
oligosaccharides), probiotics (e.g. lactobacilli and bifidobacteria) and long-chain poly unsaturated fatty
acids.
5.3 Impact of nutritional interventions in the post-
neonatal phase on immune related parameters
In this paragraph, the impact of nutritional interventions on the immune competence in the adult
phase is discussed. It is based on research in calves, weaned pigs, adult mice, laying hens, ducks,
broilers (> 10 d), and humans. The results are shown in Table 5, whereas more details are provided in
Appendix 14.
Microbiota parameters
Dietary supplementation of rice bran [116], quercitine [117], alfalfa [118], bacillus subtillis [119],
antimicrobial peptide A3 and P5 [120], Buforin II [121] and lysozyme [122] reduced the amount of
pathogenic bacteria (e.g. Clostridia, E. Coli), whereas in some studies the number of Lactobacilli and
Bifidobacteria was increased
Gut integrity
The gut integrity was improved by dietary addition of glutamine [123], black cumin [124], bacillus
subtillis [119], antimicrobial peptide A3 and P5 [120], Buforin II [121] and lysozyme [122]. The
improved gut integrity was shown by greater villus height and reduced crypt depth, and in some
studies an increased production of tight junction proteins, reduced lesion scores and less bacterial
translocation from the gut to the spleen.
Immune cells
Several dietary interventions positively affected immune cells. Such effects were found after
supplementation of glutamine [123], chitosan [125], garlic botanical [126], rice bran [116], alfalfa
[118], black cumin [124], bacillus subtillis [119], and Lactobacillus delbrueckii subsp. Bulgaricus
[127]. These interventions affected a wide range of immune cells:
 Increased IgG, IgA and secretory IgA levels
 Increased numbers of TNF-α, IL-1β cells
 Increased numbers of myeloid dendritic cells (CD11c+CD11b+ DCs) in the Lamina propria
 Increased proliferation of T and B lymphocytes
 Increased number of goblet cells
 Increased or decreased number of CD4+ cells and decreased CD8+ cells
 Increased ratio between CD4+/CD8+
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 Increased number of monocytes
 Ratio between CD8+/CD3+ in human peripheral blood.
 Ratio between CD16+56 (NK cells)/CD45+ in human peripheral blood.
Gene expression
Gene expression data were only provided in limited number of studies. In these studies, Lactobacillus
delbrueckii subsp. Bulgaricus [127], lysozyme [122], Buforin II [121], and rice bran [116] were used
as dietary interventions. These gene expression data showed:
 a reduced cytokine quantification in human serum
 an increased Lysozyme activity and lysozyme g2 mRNA content
 an increased expression of surface IgA on B220+ B cells in Peyers Patches
 an enhanced expression of protective factors (HGF, hepatocyte growth factor, reg-3 gamma,
regeneration protein gamma, TFF-3, and trefoil factor-3)
 an enhanced expression of TGF-β1, transforming growth factor β1; VEGF, and vessel endothelium
growth factor.
Performance parameters
Dietary addition of quercetin [117], black cumin [124], bacillus subtillis [119], antimicrobial peptide
A3 and P5 [120], Buforin II [121] and lysozyme [122] resulted in improved animal performance.
Improved performance was shown by a decreased FCR and an increased egg mass production, daily
gain, nutrient digestibility and retention. In some experiments [121, 122], animals were challenged
with pathogenic bacteria, and although animal performance was negatively affected by the challenge,
the dietary interventions could partly prevent this reduced performance.
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Table 5 Effects of dietary interventions during the post-neonatal phase on immune related parameters
Nutritional factors Effect Marker Ref.
Amino acids
Glutamine Improved immune response and increased autophagy of liver cells of weaned calves
(35 – 49 d of age).
CD4+, monocytes, the ratio of CD4+/CD8+, villus height and crypt
depth of intestine, the autophagy level of liver cells.
[123]
Plants and herbs
Chitosan Dietary supplement with chitosan (0.5 – 1.0 g/kg), a natural alkaline polysaccharide,
and a key structural component of helminths, arthropods, and fungi, improved
humoral and cellular immune responses of weaned piglets.
Serum IgG, secretory IgA in ileum mucosal surfaces, serum specific





Supplementation of plant extracts in PRRSV challenged weaned pigs reduces the
adverse effects of PRRSV by improving the immune responses.
B cells and CD8+ T cells, TNF-α, and IL-1 β [126]
Quercetin Dietary supplementation of quercetin improved performance of laying hens by
modulation of the intestinal environment and liver superoxide dismutase content.
Increased rate of lay, decreased FCR, decreased population of total
aerobes and coliforms, increased population of Bifidobacteria.
Increased activity of Cu-Zn-superoxide dismutase (antioxidant).
[117]
Alfalfa Dietary alfalfa meal supplementation increases intestinal microbial community
diversity and improves of the immune response growing egg-type ducks
Linear effect of Alfalfa dosage on T and B cell proliferation. No effects
on IgA, IgG and IgM. Molecular analysis of the caecal and faecal DNA





Regardless of supplementation level, dietary inclusion of black cumin decreased E. coli
enumeration in ileal digesta and improved serum lipid profile and eggshell quality,
whereas the best intestinal health indices and haying hens' performance were
obtained by at least 2% black cumin seeds.
Black cumin supplementation resulted in Increased relative pancrease
weight, reduced E. coli counts, increased villus height and reduced
crypt depth, increased goblet cell
numbers and lamina propria lymphatic follicles.
[124]
Prebiotics
Resistant starch (RS) Suppression of many immune response pathways, including the adaptive and innate
immune system, as well as cell division. RS increased the relative abundance of
several butyrate-producing microbial groups and reduced the abundance of
potentially pathogenic microbial strains.
Colonic transcriptome profiles, oxidative metabolic pathways, such as
the tricarboxylic acid cycle and b-oxidation, the nuclear receptor
peroxisome proliferator-activated receptor gamma,
[128]




4.5 g/kg BS 1–2 fermentation biomass had beneficial effects on weanling pigs
performance, CTTAD of nutrients, cecal microbiota, serum immunoglobulins and
intestinal morphology.
ADG, G:F, digestibility of DM, GE and CP, serum IgA and IgG, cecal Cl.
spp. and coliforms, villus height and VH:CD (duodenum, jejunum and
ileum).
[129]
Nutritional factors Effect Marker
Lactobacillus delbrueckii
subsp. bulgaricus
Immunomodulation induced by L. delbrueckii subsp. bulgaricus could favour the
maintenance of an adequate immune response.
Slowing the aging of the T cell subpopulations and increasing the






AMP-A3 and P5 have potential to improve performance, nutrient digestibility,
intestinal morphology and to reduce pathogenic bacteria in weanling pigs
Performance, nutrient digestibility, fecal Clostridium spp. and
coliforms, anaerobic bacteria, gut morphology
[130]
Buforin II Buforin II protects small intestinal mucosal membrane integrity of weaned pigs. Increasing tight junction proteins, enhancing the expression of
protective factors, reducing hemolytic E. coli concentrations in the
Intestines.
[121]
Lysozyme Exogenous lysozyme could decrease C. perfringens colonization and improve intestinal
barrier function and growth performance of chickens.
A reduction of C. perfringens in the ileum and of the intestinal lesion
scores, less overgrowth of E. coli and Lactobacillus in the ileum and
less intestinal bacteria translocation to the spleen, and improved
intestinal lysozyme activity in the duodenum, and improved feed
conversion ratio of chickens.
[122]
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5.4 Mode of action of dietary interventions on immunity
In this paragraph, the mode of action of the mentioned dietary interventions is briefly described. This
paragraph is partly based on two review reports regarding this topic [131, 132]
Fungal and bacterial cell wall (β-glucans)
β-Glucans bind Dectin-1-like receptor on animal cells (e.g. neutrophils, monocytes). This supports the
innate immunity by increased neutrophil functioning (i.e. production of reactive oxygen species,
cytokine production), resulting in reduced susceptibility for pathogen invasion (e.g. Salmonella
enteritidis).
Mannan-oligosaccharide (MOS)
MOS acts as a competition molecule for the adhesion of certain bacterial species in the gut, thereby
reducing the risk of diseases. Next to this, MOS also has an anti-inflammatory working, but exact
mode of action is not known. However, MOS was also reported to have an increased inflammatory
response (i.e. phagocytosis and complement pathways).
Alfalfa
Alfalfa was shown to increase heterophil functioning and was also shown to prevent Salmonella
enteritidis infection in molting chicken.
Amino acids
Several amino acids were found to alter histone and DNA methylation/acetylation and thereby to
regulate gene expressions. A similar working mechanism might be possible in other organs/cells. No
direct link of gene expression and immune functioning under influence of amino acids is reported yet.
However, amino acids were reported to activate and proliferate lymphocytes, NK cells and
macrophages and to alter the acute phase protein response.
Poly unsaturated fatty acids (PUFA)
PUFA react via the PPAR and RXR on cells and thereby affect eicosanoid releases. Additionally, PUFAs
are also incorporated in cell membranes and influence cell functioning depending on PUFA type and
concentration. Finally, PUFA are known for their regulation of gene expression, possibly via epigenetic
mechanisms (in humans). Consequently, PUFAs reduce inflammatory response in macrophages and in
T cells and also reduce the acute phase response. They are reported to stimulate antibody response.
Chicken become less vulnerable to humoral (B cell) associated diseases, but more vulnerable to
cellular (T cell) associated diseases. Also other cells are influenced. PUFA are reported to improve
epithelial integrity in the gut. The (n-3) LCPUFA metabolites induce eicosanoid production, alter gene
expression, and modify lipid raft composition, altering T-cell signalling; all contribute to immunological
functional changes. However, the roles of these mechanisms and the types of T or other
immunological cells involved remain unclear at present. Moreover, the effect of (n-3) LCPUFA on the
immune system of infants may vary according to dose, time of exposure, and profile of the immune
system (T-helper, Th1/Th2). Most of the interventional studies in infancy have been performed for the
prevention of allergy. They all confirmed influence on T-cell function and cytokine profiles, but
clinically beneficial effects are more conflicting. Supplementation of the maternal diet in pregnancy or
early childhood with (n-3) LCPUFA is potentially a non-invasive intervention strategy to prevent the
development of allergy, infection, and possibly other immune-mediated diseases. However, any long-
term in vivo effects on (n-3) LCPUFA early in life for immuno-modulatory defence in infants and later
on immune status and health remain to be assessed [133].
Spray-dried animal plasma
The immune competence improving effects of spray-dried animal plasma in young pigs is most likely
mediated by the IgG component in the plasma. The IgG prevents viruses and bacteria from damaging
the gut wall, thereby resulting in a more functional intestinal wall, improves intestinal morphology and
enzyme activity as evidenced by increased villus surface area, and increased mucosal maltase and
lactase activities [134].
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Minerals
Mineral deficiencies are well described in literature with often detrimental immuno modulatory
influences. Minerals are also reported to affect macrophage functioning and to reduce inflammation
(as antioxidants) by protection of neutrophils from oxygen-derived radicals. Also (pro-inflammatory)
gene and receptor expression is influenced by minerals. Also lymphocytes require selenium for better
functioning. Next to this, the essence of minerals for gut microbiota should not be forgotten.
Vitamins
Vitamin serve as antioxidants in the body and thereby protect cells from oxygen damage.
Inflammation and macrophage activity were reported to be reduced, although macrophage activity
was also reported to be increased. Vitamins were also reported to induce DNA methylation and alter
the immune response, although no direct link between these observations was proven.
Seaweed extract
The reduction in colonic E. coli and Enterobacteriaceae populations may be the result of the
agglutination properties of seaweed extract, thereby preventing the attachment to epithelial cell
surfaces and subsequent colonisation of mucosal surfaces [63]. Seaweed inclusion post-weaning
tended to up-regulate colonic MUC2 mRNA expression. Mucin, the primary component of mucus,
functions as a biophysical barrier against enzymatic, mechanical insult and pathogenic invasion within
the GIT. The fibrous components of Laminarin may stimulate the colonic mucosa or may have a direct
effect at the cellular level because of becoming internalized by intestinal epithelial cells and gut-
associated lymphoid tissue cells. Alterations in colonic microflora composition may also directly
influence mucin synthesis and secretion from goblet cells. The usual up-regulation of intestinal
inflammatory cytokine gene expression in ileal and colonic tissues after weaning was not observed or
tended to be lower in pigs weaned from seaweed-supplemented sows. Seaweed, therefore, seems to
modulate the production of pro- and anti-inflammatory cytokines, which might be beneficial to animal
health and performance.
Probiotics
In vitro studies have shown that Sachoromyces Cerevisiae secretes anti-inflammatory factors and
inhibits the phosphorylation of both p38 and ERK1/2 kinases after co-culture of porcine intestinal
epithelial cells with ETEC [135, 136]. Supplementation of Lactobacillus rhamnosus and Bifidobacterium
lactis to pregnant women increased the adiponectin content of their colostrum [72]. The assumed
health effects of adiponectin are mediated through its anti-inflammatory properties via regulation of
the expression of proinflammatory cytokines and through its insulin-sensitizing properties via
inhibition of liver gluconeogenesis and promotion of fatty acid oxidation.
Lysozyme
Toxins produced by C. perfringens may destruct the mucosal tissue, causing macroscopic lesions in
the duodenum, jejunum and ileum. This results in a disturbance of the interface between enterocytes
and the lamina propria, which might induce a strong inflammatory response in birds, thereby
negatively affecting digestive functions and impairing nutrient utilization, finally suppressing bird’s
performance. Lysozyme is suggested to have a direct inhibitive effect on C. perfringens proliferation
and its immune modulating activity. Based on in vitro experiments [137] is was concluded that
lysozyme could not only kill C. perfringens, but also reduce the production of α-toxin, the causative
agent for intestinal lesions. Other in vitro experiments showed that lysozyme stimulates
immunoglobulin production of specific blood lymphocytes [138]. After absorption of orally
administered lysozyme in the gut, plasma levels of lysozyme will increase, which could produce
systemic effects like an increased activity of monocytes and macrophages [139]. Lysozyme has been
reported to interact with intestinal bacteria to liberate immune-modulating peptidoglycans and Peyer’s
patches, and intraepithelial lymphocytes to activate the host’s immune system [140].
Rice bran
It is suggested that various bioactive and prebiotic components in rice bran, e.g. γ-oryzanol,
polyphenols, fatty acids, essential amino acids and micronutrients, are involved in the enhancement of
immunity [141].
Livestock Research Report 800 | 61
Lactobacilli
Lactobacilli are able to stimulate the number and activity of NK cells. NK cells play a critical role in
immune surveillance against the development of tumors and viral infections, and intestinal microflora
can modulate NK activity [142]. It is suggested that Lactobacilli stimulate the activity of the thymus
gland [127]. Lactobacilli could reduce the IL-8 content in the serum, confirming that some probiotics
are able to inhibit the production of pro-inflammatory cytokines [143]. Moreover, Lactobacilli
supplementation was associated with a very marked increase in hBD-2 antimicrobial molecule in
serum, suggesting an enhancement in the innate immunity through defensins induction [144].
Lactobacilli, therefore, do not only have local effects in the intestinal mucosa, but also in the
peripheral blood.
Plant extracts
Plant extracts are able to reduce serum TNF-α and haptoglobin, white blood cells and lymphocytes,
and to mitigate villus atrophy after an E. coli challenge, thereby modulating the systemic inflammation
caused by E. coli infection [126]. TNF-α is one of the most important cytokines released especially
form macrophages and monocytes, in response to bacterial cell wall products and bacterial toxins. The
effects of plant extracts on white blood cells and TNF-α showed that they may alleviate the
overstimulation of the systemic immunity and early immune response in E. coli infected pigs. Plant
extracts could reduce the recruitment of macrophages and neutrophils in the ileum of E. coli infected
pigs, indicating that these reduce both systemic and local inflammation.
Buforin II
Buforin II kills E. coli by penetrating the cell membrane, subsequently inhibiting cellular functions
[145]. Buforin supplementation could decrease the jejunal and ileal mucosal lymphocyte amount as
well as the calprotectin level. Calprotectin exerts antimicrobial effects through competition for zinc and
by preventing bacteria from binding to mucosal epithelial cells. Buforin II significantly increased goblet
cell amounts and the expression level of tight junction proteins (VEGF, HGH, Reg-3γ, TGF-β1, and
TFF-3) in the jejunum and ileum. HGF acts on a wide variety of epithelial cells, as a mitogen
(stimulation of cell growth), a mitogen (stimulation of cell motility), and a morphogen (induction of
multicellular architecture), and is considered to be a key molecule for construction of structure during
organ regeneration. TFF is a secretory protein expressed in gastrointestinal mucosa and may protect
the mucosa from insults, stabilize the mucus layer and affect healing of epithelium [146].
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6 Interaction between gastro-intestinal
and airway mucosal immune systems
6.1 Immune system of the respiratory tract
The respiratory tract is morphologically and functionally separated in the upper and lower respiratory
tract (Figure 7). The lower respiratory tract is formed by the pulmonary parenchyma consisting of the
bronchial passages in the lungs, and their associated alveoli (where gas exchange actually takes
place). This lower part of the respiratory tract is protected mainly by a locally functioning mucosal
immune system. Alveolar macrophages, present in the lumen of the alveoli, participate with other
cellular and humoral factors in the non-specific defence of lungs [147, 148]. The humoral component
of specific pulmonary defence is represented by the antibodies present in alveolar fluid. Locally
produced IgG antibodies prevail in lungs, but lower amounts of IgA antibodies are also present [149].
The locally functioning specific immune system of the lower respiratory tract is not likely to be
significantly modulated by nutritional intervention (unless the animal is suffering from an impaired
immune system due to overt nutritional deficiencies) and will therefore not be the focus of this
literature review.
Figure 7 The upper and lower respiratory tract
The upper respiratory tract formed by the nasal cavity, the pharynx and larynx. Just like for the lower
respiratory tract, a highly complex and effective system of non-specific immune mechanisms operate
that can eliminate more than 90% of the microorganisms the penetrate the respiratory tract [150].
The mucociliary apparatus is on one of the most significant systems for the protection of the mucosa.
Its primary role is to remove incoming dust particles and microorganisms. The mucociliary apparatus
consists of mucus producing cells and ciliary epithelium. Each of these ciliary cells contain 200-3000
ciliae that constantly move the mucus with trapped dust and microbes outwards, till it can be removed
by coughing and/or swallowing. In addition the mucus contains a number of substances with
antimicrobial activity like lactoferrin, defensins (antimicrobial peptides) and lysozyme (weakens
bacteria by breaking down part of its cell wall).
The upper respiratory tract  is also protected by a specific mucosal immune system that is partly
connected to other mucosa of the body. Together this mucosal immune system is referred to as the
“common mucosal immune system”. The primary specific defence at this mucosa is formed by IgA
antibodies [151].
64 | Livestock Research Report 800
6.2 The “common” mucosal immune system
The common mucosal immune system referred to the fact that antigenic stimulation at any inductive
site of the mucosal immune system results in a specific immune response characterized by IgA
antibody production in all of the other mucosa included in this system[152, 153]. Until recently this
theory was general accepted [154]. However, it is clear from vaccine studies with cholera toxin that
the degree of interconnection varies quite extensively [155, 156]. Whereas vaginal or rectal mucosal
vaccination results in IgA production only at the vaccination site, intranasal vaccination induces IgA in
the upper and lower airways, as well as in the vagina and head/neck area, and oral immunization
results in IgA being produced in the upper airways, head/neck area, digestive system, and in breast
tissue (Figure 8).
Figure 8 The “common” mucosal immune system. Depending on the administration route of the
mucosal model antigen cholera toxin B (CtxB), specific secretory IgA can be detected at
different mucosal surfaces.
In addition, intragastric feeding results in lower IgA production in the upper airways than normal
feeding via the mouth [157].
6.3 Gastrointestinal Immunity.
The intestine is the largest immune organ in the body and actively responds to potentially harmful
pathogens and antigens, while creating and maintaining tolerance (unresponsiveness) to other
antigens and beneficial commensal and symbiotic micro-organisms. The gastrointestinal mucosal
barrier combines a physical barrier with the production of transmembrane TLRs and cytoplasmic
nucleotide binding oligomerization domains (NOD) receptors as members of the innate immune
system [2]. TLR act as microbial pattern recognition receptors binding ligands from the gut lumen and
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determine the interaction with host-immune defence, immune cell recruitment and mucosal
inflammation. As shown in Figure 9, the intestinal immune barrier starts from the lumen with an
extracellular, luminal mucus layer produced by goblet cells in the epithelium. This barrier blocks
access of bacteria and other luminal compounds to the mucosal lymphoid follicles and provides
intestinal homeostasis. Immune trafficking mainly occurs in the small intestine, peaks in the ileum,
and occurs to a lesser extent in the colon. The gut gatekeepers comprise mucus layer and epithelium
consisting of enterocytes responsible for nutrient degradation and uptake, and mucus-producing
goblet cells [158]. Enteroendocrine cells and mast cells release hormones, neurotransmitters such as
serotonin, and immune-modulatory mediators. Paneth cells in the small intestinal crypts release
antimicrobial peptides regulating the microbial ecosystem.
Figure 9. Stage I. Luminal processes: Bacterial  ecology, metabolites (bacterial, mammalian), and
‘defensive’ molecules (mucins, antimicrobial proteins). Stage II. Epithelial processes: enterocytes
(absorptive functions, permeability), goblet cells (mucin), enteroendocrine cells (signal molecules;
hormones, neurotransmitters (5HT)), Paneth cells (antimicrobial proteins, RegIII proteins), and M-
cells (transcytosis of bacteria). Stage III. Lamina propria, immunological effects: T-cells, plasma cells
(secretory IgA), dendritic cells, Peyer’s patches/ lymphoids and mast cells, and neurones
(e.g. visceral pain perception). Stage IV. Systemic markers: blood, PBMC, faeces, saliva, immune
tissue (e.g., tonsils), and urine.
The lamina propria, that contains 75% of the body’s lymphocytes, harbors intraepithelial T and B
lymphocytes and CX3CR1+ dendritic cells (DCs). The T-cells release antimicrobial peptides after
epithelial barrier disruption, whereas DCs can actively participate in sampling of bacteria from the gut
lumen, activate Th17 cells, and generate regulatory T cells (T-reg). In the lamina propria,
NKp46+RORt cells are found that release IL-22 in response to microbiota and lead to Th17
expansion. A distinct population of CD103+ DC generates tolerance by inducing T-reg formation after
migration to the mesenteric lymph nodes. Finally, secretory IgA plasma cells provide immune deletion
of pathogens and toxins within the lumen of the intestine. This intestinal mucosal immune system can
be manipulated with functional foods and nutraceuticals impacting on the commensal microbiota in the
gut lumen [159, 160]. Any dysfunction sensed by the intestinal immune barrier will immediately result
in either local disorders, or infection and can even result in serious systemic disorders all deleterious
to health [161].The immune system in the mouth and upper respiratory tract: inductive sites for
mucosal immunity.
A proper understanding of the anatomy of mucosal immune tissues is important for designing rational
approaches to enhance immunity in the upper airways. This section will focus on the anatomical
structure of the upper airways and the presence of immunological tissues in the upper digestive tract,
i.e. the mouth and throat.
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Immunological tissues in the head/neck area are mainly structured in tonsils, lymph nodes and lymph
follicles. The largest area of contact between food and nasal contents and the immune system occurs
in the area where nose and mouth come together. As shown in Figure 10, the pharynx is surrounded
by a number of structured lymphoid nodules (tonsils), comprising the lingual tonsil, the
nasopharyngeal tonsils (adenoids), the palatine tonsils and tubal tonsils. Together these are named
Waldeyer’s ring.
Figure 10 The tonsils are organized in Waldeyer’s ring, and line the nasopharynx (from [162]). These
immunological structures are the first to come into contact with food components
The term Waldeyer’s lymphoid pharyngeal ring is mainly used in literature in human studies. In
animals, these tissues are described as nasal associated lymphoid tissue (NALT) [163, 164]. In small
laboratory animals the NALT is present in the floor of the nasal cavity as paired lymphoid aggregates,
but no comparable aggregates have been found at these sites in farm animals. In contrast, the NALT
of farm animals more closely resembles the lymphoid tissues of the Waldeyer’s ring, as seen in
humans. The tonsils of the pig e.g. are located in the soft palate, between the respiratory and
digestive tracts. Like in humans, the tonsils in pigs are part of the immune system of the respiratory
as well as the digestive mucosae and they are of great importance in porcine defensive mechanisms
against infectious agents. In cattle, sheep, pigs and horses, larynx-associated lymphoid tissue has also
been described on the epiglottis [165].
The back of the tongue also contains lymphoid follicles (lingual tonsil).  In addition, dispersed in the
mucosal tissues of the mouth large numbers of antigen-presenting cells, including Langerhans cell-like
dendritic cells (DC), are present. The tonsils and adenoids have antigen-retaining crypts, and the
reticulated epithelium lining the tonsillar crypts is probably an antigen entry portal, specialized in
transporting antigens to the subepithelial tissue [166, 167]. The adenoids, but to a much lesser extent
the palatine tonsils, have epithelia that have well developed tight junctions that are important for their
barrier function (Ogasawara et al., 2011). Interspersed are M cells and DC that contribute to antigen
sampling. Furthermore, tonsillar epithelium contains the toll-like receptors 2 and 3 (TLR2 and TLR3),
and is thus capable of responding to selected bacterial as well as viral ligands [166].
Interestingly, because of the anatomical structure of Waldeyer’s ring, the NALT in humans and in pigs
is exposed to food as well as to airborne antigens (bacteria, viruses, allergens). Airway pathogens and
aeroallergens, present in nasal secretions, can be swallowed and thus become available to the
intestinal immune system, which may result in immune effects in both mucosal compartments (i.e.
respiratory and gut) due to recirculating specific B-cells. This is in contrast to the situation in mice, in
which the oral and nasal cavities are separated. In fact, mice have recently been shown to have
respiratory M cells in the nasopharynx that play an important role in sampling airway-related antigens
[168], but in humans, and probably also in pigs, sampling does not seem to take place across the
nasal epithelium – suggesting that immune sampling of the nose takes place in Waldeyer’s ring.
The importance of tonsils as antigen sampling sites is evidenced by the fact that removal of nose and
mouth tonsils results in strongly decreased IgA response to live oral polio vaccine, indicating their role
in inducing mucosal immunity to this viral pathogen [169].
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In addition to the Waldeyer’s ring, many lymph nodes are present in the head/neck area (Figure 11).
The most important of these are the submandibular lymph nodes located beneath the jaw, and the
cervical lymph nodes that are located at the side of the neck. As reviewed by Brandtzaeg [5], after
antigens are captured by the lymphoid tissue in the nose and mouth, immune cells traffic to the
draining lymph nodes, which are represented by the cervical lymph nodes. Therefore, in addition to
the fact that nasal secretions and swallowed foods come into contact with each other in Waldeyer’s
ring (Figure 12), immune cells in the cervical lymph nodes may simultaneously come into contact with
airway pathogens, as well as with food ingredients.
Table 6 MALT structures described in cattle, sheep/goats, pigs and horses
Figure 11 Location of lymph nodes in the head and neck. Distribution of lymphoid tissues of
Waldeyer’s ring (1–pharyngeal tonsil, 2–tubal tonsil, 3–tonsil of the soft palate, 4–
(entrance to) palatine tonsil, 5–lingual tonsil), LTALT (6) and NALT (7) in pig, median (a)
and transversal section (b, plane indicated).
IgA is the immunoglobulin of choice in mucosal tissues, as it is a non-inflammatory immunoglobulin
with limited effector functions that can exclude pathogens from entering the tissues, but does not
promote inflammation. More IgA is produced in the mucosal tissues than all other immunoglobulin
isotypes in the body, and 3-5 grams of IgA is excreted in to the human GI tract each day [170].
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Figure 12 Antigen sampling and routing of immune cells from Waldeyer’s ring to the lymph nodes
in the neck (cervical lymph nodes) and mucosal tissues (from Brandtzaeg [5]).
After capturing of antigens in Waldeyer’s ring the antigens are transported by immune
cells to the cervical lymph nodes, where the immune activation takes place. Upon
activation, the immune cells recirculate through the blood and home selectively to the
upper airways, where they confer protection against pathogenic substances, e.g. by
producing IgA and by memory T cell responses.
Furthermore, dispersed Langerhans-like dendritic cells (LC) are present in the mucosal tissues in the
mouth [171] suggesting that an effective immune response against pathogens that enter the mouth
mucosa already can induce an immune response. These LC-like cells are present in the palatum,
tongue (lingua), cheeks (bucca), sublingual, and in the vestibulum. As certain subsets of DC in the GI
tract are known to sample their environment across epithelia and mucus layers, the LC in the mouth
are expected to sample protein antigens in the oral mucosa in a similar manner. Small molecules can
be taken up directly across the epithelium, as it is well established that sublingual administration
(under the tongue) of small molecule drugs leads to rapid absorption.
Taken together, these findings demonstrate that the mouth and throat are important inductive sites
for initiating specific IgA secretion at the mucosal surfaces of the upper respiratory tract.
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Figure 13 Putative scheme for compartmentalized migration of B cells from inductive (top) to
effector (bottom) sites.
Depicted are more or less preferred pathways (graded arrows) presumably followed by
mucosal B cells activated in nasopharynx-associated lymphoid tissue (NALT) represented
by palatine tonsils and adenoids, bronchus-associated lymphoid tissue(BALT), and gut-
associated lymphoid tissue(GALT) represented by Peyer’s patches, appendix, and colonic-
rectal isolated lymphoid follicles. Homing molecules integrating airway immunity with
systemic immunity are encircled in red. Adapted from Brandtzaeg [5]. MEC, mucosae-
associated epithelial chemokine; TECK, thymus-expressed chemokine.
6.4 The respiratory tract in pigs and its immune system
As shown in Figure 13, the organised mucosa-associated lymphoid tissue (MALT) is strategically
located at different antigen entry sites into the body to allow efficient antigen sampling from mucosal
surfaces. Based on the anatomical localisation, MALT structures of the respiratory tract can be
subdivided into nose-associated lymphoid tissue (NALT), lymphoid tissues of Waldeyer’s ring, larynx-
associated lymphoid tissue (LTALT) and MALT which is present at the site of bronchial ramification as
bronchus-associated lymphoid tissue (BALT) [165]. This organised lymphoid tissue is specialised in the
recognition and processing of antigens, and in the primary activation of B lymphocytes. These
aggregates of organised lymphoid tissue resemble Peyer’s patches of ileum and both are involved in
the mucosal immune system, playing a key role in this immune system. They are the sites of mucosal
immune response induction [172]. MALT contains lymphatics which transport immune cells and
antigens to regional lymph nodes that can therefore be called part of the inductive sites of mucosa and
augment the immune responses [165].
BALT does not develop in all pigs and some other animal species such as mice, cats, dogs, humans,
primates. It only develops after contact with pathogens, hence usually after an infection of the
respiratory tract [173] [174].
Provided BALT develops in pigs, its structure and in particular its topography differ in certain aspects
from those in the other animal species studied to date. The T- and B-lymphocyte-containing areas are
not as clearly separated from each other as is the case in other animal species [174]; BALT in pigs is
usually localised at the site of ramification of the bronchioles and to a lesser extent in small, cartilage
non-supported bronchi [175]. Due to the fact that BALT occurs non-constitutively in some animal
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species, the essential role of BALT in the induction of mucosal response in respiratory tract is
disputable.
6.5 Secretory IgA: Designed for Anti-Microbial Defence
and minimal mucosal inflammation
IgA is the most produced (66 mg/kg/day) antibody class in humans and most likely also in farm
animals. It is the main antibody in mucosal tissues, including the upper respiratory tract, the
gastrointestinal tract and the urogenital tract and is very important to protect against microbial
infection of the mucosal tissue. At mucosal sites IgA is present in two distinct forms that are referred
to as dimeric IgA (dIgA) and secretory IgA (SigA). Both are produced as dimeric molecules by plasma
cells in the mucosal tissue, stimulated by antigens that target the mucose. The IgA dimers are linked
via their Fc-tails by a polypeptide called “J-chain”. Only this dimeric IgA can bind to the polymeric Ig
receptor (pIgR). From the basolateral surface of the epithelial cells the pIg-pIgR complexes are taken
up by endocytosis and then extruded into the lumen after apical cleavage of the receptor (Figure 14).
Part of the pIgR, the secretory compoment (SC), remains bound to the dimeric IgA and has stabilizing
(protease-resistant) and innate functions in the secretory antibodies.  Pentameric IgM can be
transported by the same mechanism as dIgA and can also be found at many mucosa, but at lower
levels than IgA. In the gut, induction of B-cells occurs in gut-associated lymphoid tissue, particularly
the Peyer's patches and isolated lymphoid follicles, but also in mesenteric lymph nodes. IgA plasma
cell differentiation is accomplished in the lamina propria to which the activated memory/effector B-
cells home (47). The airways also receive such cells from nasopharynx-associated lymphoid tissue
but by different homing receptors (41). This compartmentalization is a challenge for mucosal
vaccination, as are the mechanisms used by the mucosal immune system to discriminate between
commensal symbionts (mutualism), pathobionts, and overt pathogens (elimination).
Figure 14 Receptor-mediated epithelial export of polymeric IgA (pIgA, mainly dimers) to
providesecretory IgA (SIgA) antibodies At the mucosal surface, SIgA antibodies together
with mucus perform immune exclusion of antigens. The epithelial polymeric Ig receptor
(pIgR) is expressed basolaterally, mainly in the intestinal crypts (glands), as membrane
secretory component (mSC) and mediates external transcytosis of pIgA (and pentameric
IgM, not shown). SIgA is released to the lumen with bound SC by apical cleavage of
pIgR, in the same manner as unoccupied pIgR (carrying no ligand) is cleaved to provide
free SC. Mucosal plasma cells produce abundantly pIgA with incorporated J chain (IgA +
J), which is required for high-affinity epithelial binding of the pIgR ligands. Modified from
[176].
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It is expected that nutritional interventions that stimulate IgA production might be helpful in
supporting the mucosal immune system, both in the upper airways as well as in the gut. In this study,
dietary addition of Bacillus subtillis, Saccharomyces cerevisiae, chitosan, rice bran, glutamine, and
spray-dried animal plasma resulted in increased secretion of IgA.
In our institute, a large number of feed additives, e.g. live yeast, mixtures of organic acids, lecithins,
butyric acid, humic acid, bioactive plant components and prebiotics, were tested as potential replacers
of antimicrobial growth promoters. In all these animal performance experiments, veterinary
treatments and mortality due to airway disorders were registered. In most of the experiments,
however, veterinary treatment and mortality levels were too low for statistical analysis, or were not
affected by the dietary interventions. The only exception was an intervention with a mixture of
medium chain fatty acids (Aromabiotic), with no veterinary treatments in the Aromabiotic group and 7
out of 220 veterinary treated piglets in both the negative and positive (with antimicrobial growth
promoter) control groups [177]. More studies, and probably with a more tailored design, should be
performed to determine the possible contribution of dietary interventions on the immune competence
of the upper airways.
Modulation of the capacity and activity of the immune system through nutrition and the use of
immuno-modulating compounds, results in innovative animal nutrition concepts and feed
interventions. The programming, development and maintenance of a properly functioning
gastrointestinal tract in pigs, with an improved resistance to pathogens and other stressors will
improve the health and welfare of animals and leads to a further reduction in the use of antibiotics in
livestock farming and saving on the cost for animal health. The identified bio-indicators of resilience
and robustness with predictive value for good animal health will result in improved feed efficiency and
ecological footprint. Nowhere did we suggest to use the immuno-modulatory compounds of relevance
to this project to treat sick animals, but we focus on strengthening the immune system to better
prepare animals for infections and, thereby, improve their resilience.
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Product group species / tissue or
cell-type








acidosis) and low (LC)
concentrate diet
biological source




calcium signaling,  MAPK pathway and
gap junction pathways.
ruminal epithelium function is
























desmoglein 1 and IGF3, 5, and 6
(genes involved in epithelial growth
and structure) and  genes involved in
ketogenesis and cholesterol
homeostasis
structural integrity of the rumen
epithelium is compromised and
cholesterol homeostasis is altered
luminal increase in










Appendix 1 Gene expression datasets of nutritional interventions in
cattle
82 | Livestock Research Report 800
pig Compound
(intervention)
Product group species, tissue or
cell-type
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oral
activation of immune and
inflammatory responses are likely are
a cause of small intestine atrophy as
revealed by a decrease in villus
height and villus/crypt ratio
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atrophy in the intestine during
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stimulation of the "Intestinal immune
network for IgA production" and
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transcription and PPARG signaling.
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intestinal immune network for IgA
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Product group species / tissue or
cell-type
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containing diet.
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coccidiosis.
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chicken Compound
(intervention)
Product group species / tissue or
cell-type
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containing, NOD-like receptor family)
genes at 1, 2, 4 and 8 hours after
challenge with endotoxin.
induction of a NOD-like receptor
family member in response to
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oral no details described no details described
start supplemented
diet; for 7 days
beginning from hatch
E-MEXP-2204 A-MEXP-1487 - AVIELA no citation
Appendix 3b Gene expression datasets of nutritional interventions in
chickens
86 | Livestock Research Report 800




consulting  general information of genes in list Genecards-Entrez 122 (list colon) general function gene 3 high up regulation of CR2, MME and CCL25, Fold change (treated over non-treated) > 10
create sublist 1; SMMP GeneDecks 122 (list colon) GO_BIOL_PROC / small molecule metabolic process
(SMMP)
25 information of human genes  is used in GeneDecks
create sublist 2; IAC DAVID - functional annotation cart 122 (list colon) GO_terms immune phenotype / adhesion / cytoskeletal
(IAC)
39 DAVID analysis using the human background
create sublist 3; transcription factors-regulators DAVID - functional annotation cart 122 (list colon) GO_terms transcription factors (TF) and regulators 3 the 3 transcription factors-regulators were also present in IAC list
Retrieve significant pathways DAVID pathway module / GeneDecks 25 (SMMP) significance (p-value and/or number of genes) 16 in case GeneDecks and David retrieve the same pathway the DAVID pathway is removed
Expression in specific Tissue - cells DAVID - Tissue expression module 25 (SMMP) significance (p-value and/or number of genes) 5 GNF_U133A_QUARTILE libraries also include subset of immune cells
Inventory of transcription factor binding sites DAVID -Protein interaction module 25 (SMMP) significance (p-value and/or number of genes) 5 UCSC_TFBS; human transcription binding sites
Relations with chemicals/substances GeneDecks 25 (SMMP) * compounds related to pathways, and  > 20% (#>4) 10 remove equivalent terms (e.g. Retinoic acid and Tretinoin)
Retrieve significant pathways DAVID pathway module / GeneDecks output list 39 (IAC) significance (p-value and/or number of genes) 27 in case GeneDecks and David retrieve the same pathway the DAVID pathway is removed
Expression in specific Tissue - cells DAVID - Tissue expression module
(GNF_U133A_QUARTILE)
39 (IAC) significance (p-value and/or number of genes) 3 GNF_U133A_QUARTILE libraries also include subset of immune cells
Inventory of transcription factor binding sites DAVID -protein interaction module (UCSC_TFBS) 39 (IAC) significance (p-value and/or number of genes) 4 UCSC_TFBS; human transcription binding sites
Relations with chemicals/substances GeneDecks output list 39 (IAC) * compounds related to pathways and  > 12.5% (#>4) 13 remove equivalent terms (e.g. Retinoic acid and Tretinoin)
** Summarize and  interpretation researcher / Genecards-Entrez-PubMed output from above
steps
literature / common genes in SMMP and IAC list) 64 genes / 10 chemicals identification of genes and related chemicals (e.g. enzyme products and substrates, chemical
receptorligands)
 "common" metabolites  (e.g. calcium, glucose, etc..) were removed
Build a network of transcription factors-regulators
GNCpro selectable Relationships; Protein
Interaction, TFactor Regulation, and  Chemical
Modification
64 (SMMP plus IAC) DAVID - functional annotation cart 3 no significant network associations
Build network to identify key-genes STITCH protein-protein-chemical association
module
64 (SMMP plus IAC) confidence level high;  score > 0.7 / no extra
interactor(s) added
18 genes / 4 chemicals non-interactors are removed from network
Identify key-genes from network and pathways researcher / Genecards-Entrez-PubMed 18  (STITCH network) central rol in network and/or specific pathway 7 genes 4 from network (NR1H4, APOC3, CYP3A4, CYP4F3) and 3 from the B Cell Receptor Signaling
Pathway
Explore alternative chemicals influencing
expression/function of key-genes
Comparative Toxicogenomics Database (CTD) 7 literature search-interpretation 21  (3 per chemical) see supplementary file MS5.
*) > 12.5% (#>4) means; the percentage of genes from the list is higher than 12.5% or more than 4.
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OFFICIAL_GENE_SYMBOL Description
ABCB1 ATP-binding cassette, sub-family B (MDR/TAP), member 1
ADAM12 ADAM metallopeptidase domain 12
ANPEP alanyl (membrane) aminopeptidase
APOA1 apolipoprotein A-I
APOA4 apolipoprotein A-IV
APOB Apolipoprotein B-100 precursor (Apo B-100) [Contains: Apolipoprotein B-48 (Apo B-48)]. [Source:Uniprot/SWISSPROT;Acc:P04114]
APOC3 apolipoprotein C-III
CCL25 chemokine (C-C motif) ligand 25
COL1A2 collagen, type I, alpha 2
CR2 complement component (3d/Epstein Barr virus) receptor 2
DAB1 disabled homolog 1 (Drosophila)
DGKA diacylglycerol kinase, alpha 80kDa
DIAPH2 diaphanous homolog 2 (Drosophila)
DPP4 dipeptidyl-peptidase 4
EGLN3 egl nine homolog 3 (C. elegans)
ENPEP glutamyl aminopeptidase (aminopeptidase A)
ETV6 ets variant 6
GBP2 guanylate binding protein 2, interferon-inducible
IFIT1 interferon-induced protein with tetratricopeptide repeats 1
MEF2B MEF2B
MEP1B meprin A, beta
MGP matrix Gla protein
MME membrane metallo-endopeptidase
NCK1 NCK adaptor protein 1
NR1H4 nuclear receptor subfamily 1, group H, member 4
OTC ornithine carbamoyltransferase
PABPC1 poly(A) binding protein, cytoplasmic pseudogene 5; poly(A) binding protein, cytoplasmic 1
PSEN2 presenilin 2 (Alzheimer disease 4)
ROCK1 similar to Rho-associated, coiled-coil containing protein kinase 1; Rho-associated, coiled-coil containing protein kinase 1
SCIN scinderin
SEPP1 selenoprotein P, plasma, 1
SLC26A6 solute carrier family 26, member 6; cadherin, EGF LAG seven-pass G-type receptor 3 (flamingo homolog, Drosophila)
SLC3A1 solute carrier family 3 (cystine, dibasic and neutral amino acid transporters, activator of cystine, dibasic and neutral amino acid transport), member 1
SLC7A9 solute carrier family 7 (cationic amino acid transporter, y+ system), member 9
SPP1 secreted phosphoprotein 1
SSX2IP synovial sarcoma, X breakpoint 2 interacting protein
TAF3 TAFII140 protein (Fragment). [Source:Uniprot/SPTREMBL;Acc:Q9BQS9]
TFF2 trefoil factor 2
XPA xeroderma pigmentosum, complementation group A
Appendix 5 David subset > Immune system phenotype / cell adhesion /
cytoskelet / transcription (IAC)
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OFFICIAL_GENE_SYMBOL Description
ABCB1 ATP-binding cassette, sub-family B (MDR/TAP), member 1
ABCG2 ATP-binding cassette, sub-family G (WHITE), member 2
ABCG8 ATP-binding cassette, sub-family G (WHITE), member 8
ACADL acyl-Coenzyme A dehydrogenase, long chain
ALDOB aldolase B, fructose-bisphosphate
AMN amnionless homolog (mouse)
APOA1 apolipoprotein A-I
APOA4 apolipoprotein A-IV
APOB apolipoprotein B (including Ag(x) antigen)
APOC3 apolipoprotein C-III
CA7 carbonic anhydrase VII
CPS1 carbamoyl-phosphate synthetase 1, mitochondrial
CYP2C18 cytochrome P450, family 2, subfamily C, polypeptide 18
CYP3A4 cytochrome P450, family 3, subfamily A, polypeptide 4
CYP4F3 cytochrome P450, family 4, subfamily F, polypeptide 3
FABP6 fatty acid binding protein 6, ileal
GLS glutaminase
KHK ketohexokinase (fructokinase)
MAOB monoamine oxidase B
OAT ornithine aminotransferase (gyrate atrophy)
OTC ornithine carbamoyltransferase
PRODH proline dehydrogenase (oxidase) 1
RBP2 retinol binding protein 2, cellular
SLC2A2 solute carrier family 2 (facilitated glucose transporter), member 2
SLC5A1 solute carrier family 5 (sodium/glucose cotransporter), member 1
Appendix 6 GENEDECKS subset > small molecule metabolic process
(SMMP)
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Term # genes % p -value genes
a
(N=25)
* Category Term Count % PValue Genes
REACTOME_PATHWAY REACT_602:Metabolism of lipids and lipoproteins 8 32 9.16E-06 APOA4, ABCG8, APOB, APOA1, APOC3, AMN, ACADL, FABP6
SUPER_PATHWAY Statin Pathway, Pharmacodynamics 6 24 4.41E-13 ABCB1, ABCG8, APOA1, APOA4, APOB, APOC3
SUPER_PATHWAY Lipoprotein metabolism 6 24 2.86E-12 ABCG8, AMN, APOA1, APOA4, APOB, APOC3
SUPER_PATHWAY Arginine and proline metabolism 6 24 1.65E-11 CPS1, GLS, MAOB, OAT, OTC, PRODH
SUPER_PATHWAY alpha-Linolenic acid metabolism 6 24 7.56E-11 ABCG8, APOA1, APOA4, APOB, CYP2C18, CYP3A4
SUPER_PATHWAY SLC-mediated transmembrane transport 6 24 7.09E-06 ABCB1, ABCG2, ABCG8, APOA1, SLC2A2, SLC5A1
REACTOME_PATHWAY REACT_13:Metabolism of amino acids 5 20 1.12E-02 GLS, OTC, CPS1, OAT, PRODH
SUPER_PATHWAY Retinoid metabolism and transport 5 20 2.31E-09 APOA1, APOA4, APOB, APOC3, RBP2
SUPER_PATHWAY Bile secretion 5 20 8.19E-09 ABCB1, ABCG2, ABCG8, CYP3A4, SLC5A1
SUPER_PATHWAY Metabolism of amino acids and derivatives 5 20 9.14E-07 CPS1, GLS, OAT, OTC, PRODH
REACTOME_PATHWAY REACT_13433:Biological oxidations 4 16 2.52E-02 CYP3A4, CYP2C18, MAOB, CYP4F3
SUPER_PATHWAY superpathway of citrulline metabolism 4 16 1.46E-09 CPS1, GLS, OAT, OTC
SUPER_PATHWAY Vitamin digestion and absorption 4 16 9.50E-09 APOA1, APOA4, APOB, RBP2
SUPER_PATHWAY Selected targets of HNF1 4 16 7.25E-08 APOA1, APOB, SLC2A2, SLC5A1
SUPER_PATHWAY ABC-family proteins mediated transport 4 16 1.38E-07 ABCB1, ABCG2, ABCG8, APOA1
SUPER_PATHWAY PPAR signaling pathway 4 16 7.05E-07 ACADL, APOA1, APOC3, FABP6
** Category Term Count % PValue Genes
UCSC_TFBS MEIS1B-HOXA9 complex 18 72 4.40E-03 CYP3A4, CYP2C18, SLC5A1, OTC, ALDOB, MAOB, ABCB1, AMN, CPS1, ACADL, ABCG8, KHK, APOB, CA7, GLS, CYP4F3, OAT, FABP6
UCSC_TFBS NF1=Nuclear Factor I/X (CCAAT-Binding Transcription Factor) 13 52 3.97E-02 SLC5A1, RBP2, ABCB1, CPS1, AMN, ABCG2, KHK, APOB, GLS, CA7, CYP4F3, OAT, PRODH
UCSC_TFBS RORA1 14 56 6.92E-02 OTC, ALDOB, MAOB, ABCB1, CPS1, AMN, APOA4, KHK, APOB, APOA1, CA7, GLS, APOC3, PRODH
UCSC_TFBS FOXO4 16 64 7.37E-02 CYP3A4, CYP2C18, SLC5A1, OTC, ALDOB, MAOB, RBP2, ABCB1, CPS1, ABCG2, KHK, APOB, CA7, GLS, FABP6, PRODH
UCSC_TFBS BRN2 15 60 8.04E-02 SLC5A1, OTC, MAOB, RBP2, ABCB1, CPS1, ACADL, AMN, ABCG2, ABCG8, KHK, APOB, SLC2A2, GLS, FABP6
*** Category Term Count % PValue Genes
GNF_U133A_QUARTILE Prostate_3rd 20 80 NA CYP3A4, CYP2C18, SLC5A1, OTC, ALDOB, MAOB, ABCB1, AMN, ACADL, ABCG2, KHK, APOA1, CA7, SLC2A2, GLS, APOC3, CYP4F3, OAT, PRODH, FABP6
GNF_U133A_QUARTILE lymphomaburkittsRaji_3rd 18 72 NA CYP3A4, CYP2C18, SLC5A1, OTC, ALDOB, ABCB1, AMN, CPS1, ACADL, APOA4, KHK, APOB, APOA1, CA7, SLC2A2, GLS, CYP4F3, FABP6
GNF_U133A_QUARTILE salivarygland_3rd 18 72 NA CYP3A4, CYP2C18, SLC5A1, OTC, ALDOB, ABCB1, CPS1, ACADL, APOA4, KHK, APOB, APOA1, CA7, SLC2A2, GLS, APOC3, CYP4F3, FABP6
GNF_U133A_QUARTILE Lung_3rd 16 64 NA CYP3A4, CYP2C18, OTC, ALDOB, MAOB, ABCB1, CPS1, APOA4, KHK, APOB, APOA1, CA7, SLC2A2, APOC3, CYP4F3, PRODH
GNF_U133A_QUARTILE fetallung_3rd 13 52 NA CYP3A4, OTC, ALDOB, MAOB, CPS1, ABCG2, KHK, APOB, APOA1, SLC2A2, APOC3, CYP4F3, OAT
****Attribute type Descriptor Score P Value Genes sharing this descriptor
COMPOUND atp 11 44 6.21E-10 ABCB1, ABCG2, ABCG8, ALDOB, APOC3, CPS1, GLS, KHK, OTC, SLC2A2, SLC5A1
COMPOUND glucose 10 40 1.65E-08 ABCG8, ALDOB, APOA1, APOA4, APOB, APOC3, GLS, OTC, SLC2A2, SLC5A1
COMPOUND lipid 10 40 1.32E-07 ABCG2, ABCG8, ACADL, APOA1, APOA4, APOB, APOC3, FABP6, OTC, RBP2
COMPOUND glutamine 9 36 1.12E-10 ABCG2, ALDOB, APOA4, APOB, CPS1, GLS, OAT, OTC, SLC5A1
COMPOUND cholesterol 9 36 5.20E-09 ABCB1, ABCG2, ABCG8, APOA1, APOA4, APOB, APOC3, FABP6, SLC5A1
COMPOUND glutamate 8 32 6.85E-07 APOA1, APOB, GLS, MAOB, OAT, OTC, PRODH, SLC5A1
COMPOUND fatty acid 7 28 1.20E-07 ACADL, APOA4, APOB, APOC3, FABP6, OTC, RBP2
COMPOUND taurocholate 5 20 6.05E-10 ABCB1, APOA1, APOB, APOC3, FABP6
COMPOUND choline 5 20 3.38E-07 APOA1, APOB, GLS, MAOB, SLC5A1
COMPOUND vitamin a 5 20 1.34E-06 APOA1, APOA4, APOB, APOC3, RBP2
Appendix 7 Pathways / Compounds / Tissue expression / Transcription
binding sequences
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Term # genes % p -value genes
a
(N=32)
* Category Term Count % PValue Genes
SUPER_PATHWAY Signaling by GPCR 12 32 4.94E-06 ADAM12, APOA1, APOA4, APOB, APOC3, CCL25, COL1A2, DGKA, NCK1, PSEN2, ROCK1, SPP1
SUPER_PATHWAY Protein digestion and absorption 6 16 2.94E-09 COL1A2, DPP4, MEP1B, MME, SLC3A1, SLC7A9
SUPER_PATHWAY Statin Pathway, Pharmacodynamics 5 13 1.21E-09 ABCB1, APOA1, APOA4, APOB, APOC3
REACTOME_PATHWAY REACT_604:Hemostasis 4 10 8.01E-02 APOB, APOA1, COL1A2, SLC7A9
REACTOME_PATHWAY REACT_602:Metabolism of lipids and lipoproteins 4 10 2.60E-02 APOA4, APOB, APOA1, APOC3
SUPER_PATHWAY Retinoid metabolism and transport 4 10 1.63E-06 APOA1, APOA4, APOB, APOC3
SUPER_PATHWAY Lipoprotein metabolism 4 10 5.11E-07 APOA1, APOA4, APOB, APOC3
SUPER_PATHWAY Selected targets of HNF1 4 10 4.63E-07 APOA1, APOB, DPP4, NR1H4
SUPER_PATHWAY B Cell Receptor Signaling Pathway 3 8 2.95E-04 CR2, NCK1, SPP1
KEGG_PATHWAY hsa04510:Focal adhesion 3 8 1.86E-01 ROCK1, COL1A2, SPP1
REACTOME_PATHWAY REACT_13:Metabolism of amino acids 3 8 1.60E-01 OTC, SLC7A9, SLC3A1
KEGG_PATHWAY hsa04640:Hematopoietic cell lineage 3 8 4.41E-02 CR2, MME, ANPEP
REACTOME_PATHWAY REACT_16888:Signaling by PDGF 3 8 3.13E-02 NCK1, COL1A2, SPP1
REACTOME_PATHWAY REACT_15518:Transmembrane transport of small molecules 3 8 1.41E-02 APOA1, SLC7A9, SLC3A1
KEGG_PATHWAY hsa04614:Renin-angiotensin system 3 8 1.93E-03 MME, ANPEP, ENPEP
SUPER_PATHWAY Amino acid and oligopeptide SLC transporters 3 8 4.19E-04 SLC26A6, SLC3A1, SLC7A9
SUPER_PATHWAY Cell surface interactions at the vascular wall 3 8 3.81E-04 APOB, COL1A2, SLC7A9
SUPER_PATHWAY Hematopoietic cell lineage 3 8 3.35E-04 ANPEP, CR2, MME
SUPER_PATHWAY Selenium Pathway 3 8 3.03E-04 APOA1, APOB, SEPP1
SUPER_PATHWAY alpha-Linolenic acid metabolism 3 8 1.79E-04 APOA1, APOA4, APOB
SUPER_PATHWAY Endochondral Ossification 3 8 1.51E-04 MGP, SCIN, SPP1
SUPER_PATHWAY Insulin Processing 3 8 7.18E-05 ANPEP, DPP4, MME
SUPER_PATHWAY Vitamin digestion and absorption 3 8 7.27E-06 APOA1, APOA4, APOB
** Category Term Count % PValue Genes
UCSC_TFBS BRACH=T or Brachyuri 26 67 1.33E-02 MEF2B, DIAPH2, EGLN3, MME, SLC7A9, DGKA, APOB, DAB1, TFF2, PABPC1, ETV6, DPP4, NR1H4, CR2, TAF3, ROCK1, OTC, MGP, ABCB1, SLC3A1, SLC26A6, NCK1, SCIN, PSEN2, COL1A2, ADAM12
UCSC_TFBS CDP=CUX1 or CUTL1 26 67 4.65E-02 DIAPH2, EGLN3, MME, SLC7A9, ENPEP, DGKA, APOA4, APOB, DAB1, APOC3, PABPC1, SEPP1, SSX2IP, ETV6, DPP4, NR1H4, TAF3, ROCK1, OTC, MGP, ABCB1, SLC3A1, NCK1, COL1A2, ADAM12, GBP2
UCSC_TFBS FREAC4 = FOXD1 25 64 1.77E-03 DIAPH2, EGLN3, MME, ANPEP, ENPEP, APOA4, APOB, DAB1, PABPC1, SEPP1, SSX2IP, ETV6, DPP4, NR1H4, CR2, ROCK1, MGP, ABCB1, XPA, SLC26A6, NCK1, SCIN, COL1A2, ADAM12, GBP2
***Category Term Count % PValue Genes
GNF_U133A_QUARTILE Cerebellum_3rd 31 79 NA
MEF2B, DIAPH2, EGLN3, MME, SLC7A9, ANPEP, ENPEP, DGKA, APOA4, CCL25, APOB, DAB1, APOA1, APOC3, TFF2, SSX2IP, ETV6, DPP4, NR1H4, CR2, ROCK1, OTC, MGP, ABCB1,
SLC3A1, SLC26A6, SCIN, PSEN2, COL1A2, MEP1B, ADAM12
GNF_U133A_QUARTILE BM-CD34+_3rd 31 79 NA
MEF2B, DIAPH2, EGLN3, SLC7A9, MME, ANPEP, ENPEP, DGKA, CCL25, APOB, DAB1, APOA1, APOC3, TFF2, SSX2IP, PABPC1, ETV6, DPP4, NR1H4, CR2, ROCK1, OTC, SLC3A1, XPA,
SLC26A6, NCK1, SCIN, PSEN2, MEP1B, ADAM12, GBP2
GNF_U133A_QUARTILE salivarygland_3rd 30 77 NA
MEF2B, DIAPH2, EGLN3, MME, SLC7A9, ENPEP, DGKA, APOA4, CCL25, APOB, DAB1, APOA1, APOC3, TFF2, SSX2IP, PABPC1, ETV6, DPP4, NR1H4, CR2, ROCK1, OTC, ABCB1,
SLC3A1, SLC26A6, NCK1, SCIN, PSEN2, MEP1B, ADAM12
GNF_U133A_QUARTILE lymphomaburkittsRaji_3rd 28 72 NA
MEF2B, DIAPH2, EGLN3, MME, ENPEP, APOA4, CCL25, APOB, APOA1, DAB1, TFF2, SSX2IP, PABPC1, ETV6, DPP4, NR1H4, CR2, ROCK1, OTC, ABCB1, SLC3A1, SLC26A6, IFIT1, NCK1,
SCIN, PSEN2, MEP1B, ADAM12
****Attribute type Descriptor Score % P Value Genes sharing this descriptor
COMPOUND calcium 15 38 8.E-07 ANPEP, CCL25, COL1A2, CR2, DAB1, DGKA, DPP4, ENPEP, MGP, MME, PSEN2, ROCK1, SCIN, SPP1, TFF2
COMPOUND glutamate 13 33 1.E-10 ANPEP, APOA1, APOB, DAB1, DPP4, ENPEP, MGP, MME, OTC, PSEN2, SLC3A1, SPP1, XPA
COMPOUND glucose 12 32 2.E-08 ANPEP, APOA1, APOA4, APOB, APOC3, DPP4, MME, NR1H4, OTC, PSEN2, SEPP1, SPP1
COMPOUND cholesterol 11 28 2.E-09 ABCB1, ANPEP, APOA1, APOA4, APOB, APOC3, DPP4, MGP, NR1H4, PSEN2, SPP1
COMPOUND lipid 11 28 2.E-06 ANPEP, APOA1, APOA4, APOB, APOC3, DGKA, MME, NR1H4, OTC, SEPP1, SPP1
COMPOUND estrogen 11 28 1.E-07 APOA1, APOB, APOC3, COL1A2, CR2, MGP, MME, NR1H4, PSEN2, SPP1, TFF2
COMPOUND retinoic acid 10 25 1.E-06 ANPEP, APOA1, APOC3, DPP4, ETV6, MGP, MME, NR1H4, PSEN2, SPP1
COMPOUND lactate 8 20 3.E-07 ANPEP, APOA1, APOB, DPP4, MME, OTC, PSEN2, SPP1
COMPOUND vegf 8 20 1.E-05 APOB, EGLN3, ENPEP, ETV6, MME, NCK1, PSEN2, SPP1
COMPOUND fatty acid 7 18 3.E-06 APOA4, APOB, APOC3, MME, NR1H4, OTC, PSEN2
COMPOUND h2o2 6 16 3.E-04 APOA1, APOB, MME, PSEN2, SEPP1, SPP1
COMPOUND taurocholate 5 13 6.E-09 ABCB1, APOA1, APOB, APOC3, NR1H4
COMPOUND vitamin a 5 13 1.E-05 APOA1, APOA4, APOB, APOC3, MME
***** pro-pre B-cell markers Bio-gps database high expression in
MME http://biogps.org/#goto=genereport&id=4311 lymphomaburkitts
CR2 http://biogps.org/#goto=genereport&id=1380 lymphomaburkitts / B lymphoblasts
CCL25 http://biogps.org/#goto=genereport&id=6370 small intestine / thymus
T or Brachyuri http://biogps.org/#goto=genereport&id=6862 B lymphocytes
Appendix 8 Pathways / Compounds / Tissue expression / Transcription
binding sequences











experimental knowledge textmining combined_sco
re
ABCB1 cholesterol 979655 -100000304 ENSP00000265724 304 0 0 0 0 0 0.272 0.8 0.833 0.974
ALDOB KHK 991083 978593 ENSP00000363988 ENSP00000260598 0 0 0 0 0.089 0 0.9 0.374 0.935
ANPEP ENPEP 982231 979556 ENSP00000300060 ENSP00000265162 0 0 0.525 0.886 0 0.16 0.9 0.752 0.922
APOA1 cholesterol 977122 -100000304 ENSP00000236850 304 0 0 0 0 0 0.9 0.9 0.954 0.999
APOA1 linoleic acid 977122 -100003931 ENSP00000236850 3931 0 0 0 0 0 0 0.9 0.86 0.985
APOA1 APOB 977122 977017 ENSP00000236850 ENSP00000233242 0 0 0 0 0.823 0.621 0.9 0.92 0.999
APOA1 APOC3 977122 976781 ENSP00000236850 ENSP00000227667 0 0 0 0 0.897 0.302 0.9 0.79 0.998
APOA4 cholesterol 988386 -100000304 ENSP00000350425 304 0 0 0 0 0 0 0.9 0.487 0.947
APOA4 APOA1 988386 977122 ENSP00000350425 ENSP00000236850 0 0 0 0.811 0.67 0 0.9 0.751 0.969
APOA4 APOC3 988386 976781 ENSP00000350425 ENSP00000227667 0 0 0 0 0.43 0 0.9 0.771 0.985
APOA4 APOB 988386 977017 ENSP00000350425 ENSP00000233242 0 0 0 0 0.668 0 0.9 0.565 0.983
APOB linoleic acid 977017 -100003931 ENSP00000233242 3931 0 0 0 0 0 0 0 0.828 0.828
APOB APOC3 977017 976781 ENSP00000233242 ENSP00000227667 0 0 0 0 0.754 0 0.9 0.852 0.995
APOB cholesterol 977017 -100000304 ENSP00000233242 304 0 0 0 0 0 0 0.9 0.963 0.996
APOC3 cholesterol 976781 -100000304 ENSP00000227667 304 0 0 0 0 0 0 0.9 0.688 0.967
CPS1 APOC3 996337 976781 ENSP00000402608 ENSP00000227667 0 0 0 0 0.817 0 0 0 0.817
CPS1 APOA1 996337 977122 ENSP00000402608 ENSP00000236850 0 0 0 0 0.722 0 0 0 0.722
CPS1 OTC 996337 975784 ENSP00000402608 ENSP00000039007 0.438 0.014 0 0 0.568 0 0.9 0.658 0.989
CPS1 APOB 996337 977017 ENSP00000402608 ENSP00000233242 0 0 0 0 0.742 0 0 0 0.742
CYP2C18 linoleic acid 980959 -100003931 ENSP00000285979 3931 0 0 0 0 0 0 0.9 0 0.9
CYP2C18 CYP4F3 980959 976453 ENSP00000285979 ENSP00000221307 0 0 0.52 0.625 0 0 0.9 0.34 0.927
CYP3A4 CYP2C18 986634 980959 ENSP00000337915 ENSP00000285979 0 0 0.519 0.737 0.068 0 0.9 0.652 0.927
CYP3A4 NR1H4 986634 984066 ENSP00000337915 ENSP00000315442 0 0 0 0 0 0 0 0.916 0.916
CYP3A4 linoleic acid 986634 -100003931 ENSP00000337915 3931 0 0 0 0 0 0 0.9 0.27 0.924
CYP3A4 ABCB1 986634 979655 ENSP00000337915 ENSP00000265724 0 0 0 0 0 0 0 0.851 0.851
CYP4F3 LTB4 976453 -100000169 ENSP00000221307 169 0 0 0 0 0 0 0.9 0.699 0.969
DPP4 ANPEP 988888 982231 ENSP00000353731 ENSP00000300060 0 0 0 0 0 0 0 0.752 0.752
FABP6 NR1H4 993380 984066 ENSP00000377549 ENSP00000315442 0 0 0 0 0 0 0 0.954 0.954
IFIT1 GBP2 990429 990142 ENSP00000360869 ENSP00000359497 0 0 0 0 0.193 0 0.9 0.412 0.945
MAOB CYP2C18 991745 980959 ENSP00000367309 ENSP00000285979 0 0 0 0 0 0 0.9 0 0.899
MAOB CYP3A4 991745 986634 ENSP00000367309 ENSP00000337915 0 0 0 0 0 0 0.9 0.366 0.932
MAOB menadione 991745 -100004055 ENSP00000367309 4055 0 0 0 0 0 0.699 0.7 0.8 0.98
MME ANPEP 988880 982231 ENSP00000353679 ENSP00000300060 0 0 0 0 0 0 0 0.752 0.752
MME linoleic acid 988880 -100003931 ENSP00000353679 3931 0 0 0 0 0 0 0 0.8 0.8
NR1H4 APOA1 984066 977122 ENSP00000315442 ENSP00000236850 0 0 0 0 0.085 0 0 0.896 0.898
NR1H4 APOC3 984066 976781 ENSP00000315442 ENSP00000227667 0 0 0 0 0.157 0 0 0.899 0.909
OAT OTC 989773 975784 ENSP00000357838 ENSP00000039007 0.472 0 0 0 0.311 0 0.9 0.543 0.979
SLC2A2 SLC5A1 984947 979723 ENSP00000323568 ENSP00000266088 0 0 0 0 0 0 0.9 0.379 0.933
SLC3A1 SLC7A9 978602 975765 ENSP00000260649 ENSP00000023064 0 0 0 0 0 0 0.9 0.913 0.99
Appendix 9 STITCH interactors (type of association and confidential
scores)
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Gene compound 1 literature compound 2 literature compound 3 literature
CR2 Tretinoin 16443354 Vitamin E 23208437 Copper Sulfate 19549813
APOC3 Ginsenosides 16297877 Drugs, Chinese Herbal 16297877 Dietary Fats 18457598
SPP1 Calcitriol 17171500 Capsaicin 22150557 Galactosamine 19913045
NCK1 Tretinoin 15498508 epigallocatechin gallate 22079256 beta-methylcholine 21179406
NR1H4 Bile Acids and Salts 15725701 epigallocatechin gallate 22178739 alpha-Linolenic Acid 15307955
CYP3A4 Calcitriol 17270371 Curcumin 17270371 9-cis-retinal 16632523
CYP4F3 Tretinoin 17218384 apple polyphenol extract 16369997 Thapsigargin 19442820
userguide; click on the hyperlink of the gene to access the CTD database, and open the tab " chemical interactions".
Sort and scroll in the list of compounds to the desired compound  to access the related literature links.







Appendix 10 Predicted chemical (Comparative Toxicogenomics
Database hyperlinks)
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Appendix 11 Detailed study information of the experiments that tested
trans-generational epigenetic effects (maternal phase)













D90 to 5d before
farrowing: 0.34 g
AKG/sow/d
D5 before to d5 after
farrowing: 1.5 g
AKG/sow/d. From d5
until weaning: 0.75 g
AKG/sow/d.








Increased % of serum
bactericidal activity and
haemolytic complement






Corn vs. coconut oil x






4 d after mating
onwards
Until birth 90 vs. 180 g/kg crude
protein; 100 g corn oil
or 50 g corn oil + 50 g
coconut oil or 10 g





exposure to a low
protein diet, which
could be overcome in
postnatal rats if the
prenatal diet included
a large amount of
coconut oil and a
small amount of corn
oil.
Lymphocyte proliferation
in thyme and spleen;
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Dosage Effect Marker Note Ref.







vs. fish oil vs. linseed
oil (40 g/kg)
Maternal intake of
fish oil changes the
offspring's antigen-
specific response.
Fish oil reduced levels of
total OVA-specific
antibodies and OVA-IgG1
titers in the pup blood.
The decrease in IgG1 was





































1) increase in the















in the expression of
several genes associated
with lipid metabolism
n-3 Fa resulted in
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Improved daily gain and
pro-inflammatory IL-1a
mRNA expression in the
ileum of pigs 11 d after
weaning.  increased villus
height.




















Sows: 1 g/kg feed
Suckling pigs: 3 x 1 g
per wk






Less shedding of ETEC
bacteria in faeces;
increased serum IgA-














2 x 4 g/d Higher expression of
a set of genes
Especially up-regulation
of IL-27 in 1- month
breast milk samples,
which is associated with
immuno-regulatory
functions.





















Sows: 3.14 x 105 cfu/g
Suckling pigs: 8.7 x
105 cfu/g










to an altered immune
response




gamma delta T cells in
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BB: 18 wk of age
Broilers: Day-old
BB: until 30 wk
of age
Broilers: 32 d of












growth potential of the
controls.
In the challenged
broilers, increased nr. of
leukocytes on d1, a
faster recovery rate of
intestinal lesions, crypts
and villus atrophy were
observed.
Increased expression


























of CD8 cytotoxic T cells,
CD2 T cells, panB cells,






Zinc and β-carotene 170 pregnant
women; 134
new-borns
Pregnant < 20 wk Until birth 30 mg/d zinc;
+/- 4.5 mg/d β-
carotene
Addition of zinc to




disease during the first
6 months of life, albeit
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Appendix 12 Detailed study information regarding the effect of nutritional
interventions on immune related parameters in pigs (neonatal
phase)
Nutritional factors n Age (start
experiment)













<3 days or 2 weeks
old





6 per group Day 7 14 days 0.671, 0.871, and
1.071% L-arginine













Day 0 Intervention at each
time-point specifically
0/2/7/14/21
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Nutritional factors n Age (start
experiment)
Duration of intervention Dosage Effect Marker Note Ref.
Vitamins/Minerals




2) high Zn (3,000 ppm
added to the basal
diet) only during wk
1; 3) high Zn only
during wk 2; 4) high
Zn during wk 1 and 2;
5) high Zn during wk 2
and 3; and 6) high Zn
for the entire nursery
period
Both traditionally
weaned (> 21 d) and
early weaned (< 14 d)




as zinc oxide during at






vitamin E and selenium 6 per group Day 3 11 days 1) FE, 1 mL containing
200 mg of Fe (iron
dextran);
2) FEE, treatment FE
plus 1 mL containing
300 IU of vitamin E (d-
a tocopherol);
3) FESEE, 1.03 mL
containing 200 mg of
Fe (iron dextran), .15
mg of Se (sodium
selenite), and 15 IU of
vitamin E (d-a
tocopherol)
one Fe injection (200
mg) for pigs from sows
fed adequate vitamin E
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Nutritional factors n Age (start
experiment)


















15 per group Day 0 is
weaning
16 days Control diet; soybean
oil (15 g/kg), Alphacell

























6 per group Day 1 Day 10-12 0, 0.5, or 5% ARA or
5% EPA diets (% is
total fatty acids)





























Short chain fatty acids 6 per group acute (4, 12, 24 h) and
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Nutritional factors n Age (start
experiment)




















Day 1 7 days GOS (4 g/L)
PDX (4 g/L), or

















pigs at day 7






















Day 1 18 days Polydextrose; 1.7, 4.3,
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Dosage Effect Marker Note Ref.




Day 2 Depending on
examination























5 mL of the porcine
competitive exclusion (CE)
culture. Challenge 1 X 10^8
cfu of EC 987
Effective against E. coli
infections in neonatal piglets
ileal, colon, cecum,
rectal swaps,  lymph









Day 0 24 days
(weaning)
Day 0, 1, 2; 2.8 × 10^9
colony forming units (CFU)
of E. faecium DSM 10663
NCIMB 10415 per g
Day 4-onwards;
1.26 × 109 CFU E. faecium
twice a day, in case of
diarrhoea 2.9 (week 1) and
5.8 (≥ week 2) × 10^8 CFU
of E. faecium










36 Day 3 18 days 10% SDAP (AP920,
American Protein















α, IFN-γ, IL-6, TGF-β,
IL-10, IL-4, IL-2, sIL-
2R, NF-κB, and SIgA)
[93]
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Appendix 13 Detailed study information regarding the effect of nutritional
interventions on immune related parameters in poultry
(neonatal phase)




Dosage Effect Marker Note Ref.
Amino acids
Arginine 48 per group Day 1 Day 1-18 control diet (100% of NRC)
Arg (120% of NRC) Lys (120% of
NRC)
Arg+Lys (120% of NRC)
Increasing dietary Arg, but
not Lys, from 100 to 120%
of the NRC
recommendation











30 per group Day 1 Day 1-18 Control diet (CD);
CD+plus L-Arg (0.20% Arg of
diet); CD plus L-Lys HCl (0.20%
Lys of diet); and CD plus L-Arg−





primary antibody titers to











~8 per group Day 1 Day 1-15 Arg; 90, 100, 110, and 120% of
NRC. Half of birds vaccinations
of Newcastle disease virus and
infectious bronchitis at day 1.
-vac birds fed an Arg-
deﬁcient diet had lower
feed conversion
compared to +vac birds
Vac+ birds had lower day
15 BW than –vac birds,
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Dosage Effect Marker Note Ref.





Day 1 Day 1-21
(samples on
day 4, 7, 14,
and 21)
1) control diet
2) control diet + 1% Gln
3) control diet + 1% Gln in
drinking water,
4) control diet + 1% Gln and 1%
Gln in drinking water
5) control diet + 4% Gln
6) control diet + 4% Gln in
drinking water
7) control diet + 4% Gln and 4%
Gln in drinking water
addition of 4% Gln to the











Day 1 Day 1-21
(samples on
day 7, 14, and
21)
1) control diet
2) control diet + 1% Gln for 4
days
3) control diet + 1% Gln for 7
days
4) control diet + 1% Gln for 14
days




1% Gln for 21 days. Higher
concentrations of bile,
intestinal, and sera IgA,






Threonine 45 per group Day 1 0-42 days dietary levels of L-threonine (0,














Methionine/Cysteine ? Day 1 Sacrificed at








0.063% Met + 0.153% Cys
improvement in the cell
mediated PHA-P
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wheat/rye-based diet compared with
a maize-based diet: induces villus
fusion,
a thinner tunica muscularis, T-
lymphocyte infiltration, more and
larger goblet cells, more apoptosis of























challenge, and their interactions
enzyme supplementation minimized
the growth suppression associated
with the C. perfringens challenge,
with the most pronounced effect























control + 4 g FOS per kg
control + lactic acid, citric acid,
ascorbic acid and propionic acid
(1:1000L water)
control + medium chain fatty
acids (1:1000 starter, 1:2000
grower)
organic acids and MCA chicks had a
better growth performance, better
digestibility, less S. Enteritidis
colonization and lower pH in the crop
and
intestines.
FOS chicks tended to have decreased












Day 0 Day 0-25 control
control + ZnB
control + 2% n-3 PUFA (SALmate)
control + 5% n-3 PUFA (SALmate)
n-3 PUFA (SALmate) supplementation
altered the intestinal Lactobacillus
species profiles, but did not alter the





















0.4% butyric acid was on par with
antibiotic in maintaining body weight
gain, and reducing E.















Dosage Effect Marker Note Ref.
Prebiotics 120 per
group
Day 0 2 feeding
phases; 1-21
and 21-42
Every 25kg portion, 1) 0.15 kg of
corn starch + 1.5 kg H2O(T1,
control);
2) diet T1 + 0.75 kg of GOS (T2);
3) 0.15 kg of corn starch + 3 kg of
GOS (T3), GOS (β-galactosidase-
treated lactose solution)
GOS selectively stimulated the fecal











Day 7 21 days Bio-MOS (mannan
oloigosaccharide S. cerevisiae)
longer jejunal villi, greater specific
activities maltase, leucine
aminopeptidase and alkaline











Day 1 Challenge day
3
β-glucan feed + no SE, β-glucan
feed + SE, control feed + SE
β-glucan feed decreases the
incidence of SE organ invasion in
neonatal chickens and up-regulating
of the functional abilities of
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Dosage Effect Marker Note Ref.
Probiotics 120 per
group




4) 1.5 kg H2O + 0.15 kg of
bifidobacteria (T4);
5) 0.75 kg H2O + 0.15 kg of
bifidobacteria + 0.75 kg of GOS (T5);
and




lactis D300 pure culture (Abiasa
Inc.)
GOS in combination with a
B. lactis-based probiotic
favoured intestinal growth











Day 1 41 days 0, 5, 10 mg (healthy matured) cecal
cultures per L drink water and 0,

















Vitamin E + Se ? ? ? 1) Basal diet, without vitamin E or
selenium (Se)
2) basal diet supplemented with
vitamin E (100 IU/kg) and Se (0.2
ppm)
Depletion affects both the
maturation of specific
lymphocyte subpopulations










Day 1 2 feeding
phases; 1-28
and 29-42
1) control group (no essential
oil[EO])
2) 100 ppm EO - thyme
3) 200 ppm EO - thyme
4) 100 ppm EO - cinnamon
5) 200 ppm EO - cinnamon
EO could be considered as a
potential natural growth
promoter for poultry at the
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Appendix 14 Detailed study information of interventions that were
tested in the post-neonatal phase




Dosage Effect Marker Note Ref.
Amino acids
Glutamine 24 calves 35 d. 14 d. 0, 8, 16 and 32
g/d.
Improved immune response
and increased autophagy of
liver cells.
Gln increased the abundance of CD4+,
monocyte and the ratio of
CD4+/CD8+, villus height and crypt
depth of intestine. The autophagy
level of liver cells was improved with






180 weaned pigs 28 d. 28 d.
(0-14 and 14-28 d)
0, 100, 500, 1000,
and 2000 mg/kg
Improved humoral and cellular
immune response; dose
dependent effects.
Positive effects on IgG and ovalbumin
IgG, secretory IgA, IL-1 and IL-2,












28 d. 10 mg/kg These plant extract improved
the immune response of
PRRSV infected pigs.
Feeding GAR increased B cells and
CD8+ T cells of PRRSV-infected pigs
The PRRSV challenge increased serum
viral load, TNF-α, and IL-1β
But feeding plant extracts reversed




Rice bran SPF-mice 4-6 wk of age 28 d. 10% rice bran Modulation of mucosal
immunity against enteric
infections and induction of
beneficial gut bacteria
IgA in B lymphocytes in the Peyer's
patches, Dendritic cells in lamina
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Dosage Effect Marker Note Ref.
Quercetin 240 laying hens 28 wk 8 wk 0, 0.2, 0.4 and 0.6
g/kg quercetin
Max. rate of lay and feed
efficiency at 0.4 g/kg. Reduced
nr. of aerobes and coliforms

















Molecular analysis of cecal and faecal





100 Laying hens 49 wk 10 wk 0, 1, 2, and 3% of
black cumin
Max. performance with at
least 2% inclusion level.
Improved villus height and reduced
crypt depth, increased numbers of




Resistant starch (RS) 10 cannulated
male pigs
17 wk of age 14 d. Digestible vs.
resistant starch
A diet high in RS provoked





response and cell division
pathways. RS also favoured
the growth of microbes that
produces organic acids and
inhibited a range of potentially
pathogenic microbial groups.
Colonic transcriptome profiles,
oxidative metabolic pathways, such as
the tricarboxylic acid cycle and b-




Livestock Research Report 800 | 109










21 d. 28 d.
2-phase feeding
(0-14 and 14-28 d)







IgG and IgA concentrations,
decreased cecal Clostridium
and Coliforms, greater villus
height.
Performance, digestibility, serum IgG
















by slowing the aging of the T
cell subpopulations and
increasing the number of
immature T cells.
More NK cells, an improvement
in the immune risk
profile (IRP), an increase in the T-cell
subsets, less pro-inflammatory
















2) Pos. control (150
mg/kg Avilamycine)
3) 60 mg/kg AMP-
A3
4) 60 mg/kg AMP-
P5





reduce pathogenic bacteria in
weanling pigs.
Improved ADG, G:F, Digestibility of
GE, CP and DM. Fewer fecal Cl. spp.
and coliforms, anaerobic bacteria.
Greater villus height and ratio villus




Buforin II 3 * 5 E. coli
challenged
weaned pigs
21 d. 21 d. 1) Control
2) 2 * 5 ml
Buforin/d
3) 2 * 5 ml  5
colistin sulphate.
Buforin II protects intestinal
mucosal membrane integrity
and can reduce hemolytic
E.coli concentrations in the
intestines of piglets.
Improved piglet performance, tight
junction proteins (e.g. calprotectin)
and expression of protective factors,
(e.g. HGF, hepatocyte growth factor;
Reg-3 gamma, regeneration protein
gamma; TFF-3, trefoil factor-3;
TGF-beta1, transforming growth
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Dosage Effect Marker Note Ref.
Lysozyme 186 male broilers d14 28 days 40 mg/kg lysozyme;
+/- challenged with C.
perfringens
A decreased C. perfringens
colonization and an improved
intestinal barrier function and
growth performance of chickens
Lesion scores,  Lysozyme activity in
duodenum, bacterial translocation to





Vitamin C + E 174, 89 treatment,
85 placebo
Age groups; 2–
5, 6–11, or 12–
35 months old
5 days Twice a day: 200 mg α-
tocopherol and ascorbic acid
100 mg or placebo
None meausered Time taken to recover from a very ill
status, fever, tachypnoea, and feeding
difficulty; and improvement in oxidative
stress and immune
response indicated by thiobarbituric
acid reacting substances (TBARS) and
response to skin antigens.
[109]
LC-PUFA 46 (Formula; n=14)
or treatment (n=
16, ) or exclusively
human milk;
n=16).
Age 7-14 days 28 days Formula or Formula
supplemented with the LCP 20
: 4n-6 and 22 : 6n-3 +
exclusively fed human milk
Early diet influences both the
presence of specific cell types and
function of infant blood immune
cells
formula fed infants had a
higher percentage of CD3+, CD4+CD28+,
and lower percentage of CD14+ cells






Age 26-39 days 28 days Formula F contained only
traces of LCP.
Formula LCP-F contained 0.5 g
LA metabolites/100 g fat and
0.8 g ALA metabolites/100 g
fat derived from egg
lipid extracts, black currant
seed oil and low EPA fish oil
Plasma Long-chain
polyunsaturated fatty acids (LCP)
levels similar to those of breast
fed infants can be achieved with
the LCP supplemented formula
used in this trial, without evidence
of adverse effects of the LCP
enrichment
Urinary malondialdehyde (MDA),
marker for oxidative stress,  excretion
was significantly higher in formula fed
infants. α-tocopherol similar between
groups, tendency for lower values in
formula (group F) fed infants
[111]
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Appendix 15 Detailed study information of interventions that were







Dosage Effect Marker Note Ref.
Prebiotics





within the ﬁrst 2
weeks of life
2 years 8 g/L scGOS/lcFOS or
placebo (8 g/L maltodextrin)
Infants in the intervention group
had signiﬁcantly lower incidence
of allergic
manifestations
Infants in the intervention group had
lower cumulative incidences for atopic
dermatitis, recurrent wheezing, and
allergic urticaria, also fewer episodes of
physician-diagnosed overall and upper
respiratory tract infections, fever







Oligosaccharides 90 term infants Day 6 or 7 27 days Placebo (maldextrin), 0.4
g/L, 0.8 g/L
Dosage-dependent effect on the
growth of Bifidobacteria and













control group, NT at 10 mg/l
and
treatment group, NT at 33.5
mg/l
Cow's milk-based formula with NT
resulted in a modest improvement
in some antibody responses in a
population of healthy term
infants, with no effect on other
markers of immune status and
growth.
T cells, B cells, NK cells, CD4+, CD8+,
CD4:CD8, CD45RA+, CD45RO+, CD25+
Antibody responses to tetanus toxoid
[114]
Nutritional factors n Age (start Duration of Dosage Effect Marker Note Ref.











control was formula only, in
the treatment group the
following was added control









The supplementation of infant
formula with B. bifidum and
S. thermophilus can reduce the
incidence of acute diarrhoea
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Appendix 15 A brief introduction to the
immune system
1.The innate immune system
The immune system protects against invading pathogens. It is divided the “innate” and the “adaptive”
or “acquired” immune system. The innate (also called “natural” or “native” immune system) forms the
first line of defence that is already present before its first encounter with a pathogen.  It consists of
anatomical and (bio)chemical barriers, humoral (soluble) components and cellular components.
1.1 Anatomical and (bio)chemical barriers
The skin forms a strong physical barrier that is hard to break for microbes. Microbes that do attach are
usually removed by “flaking” of old skin epithelium. The internal body epithelia, like that of the
respiratory and gastrointestinal tract are covered by a mucus layer that is also difficult to penetrate.
Microbes trapped in the mucus will be removed with the mucus from the body by the action of the cilia
and due to peristalsis.
The anatomical barriers are covered with antimicrobial (bio)chemical factors, lysozyme on the
skin and in tears, gastric acid in the stomach and anti-bacterial proteins (defensins) in the mucosa.
Commensal bacteria in the gut and on the skin compete with potential pathogens for space and
nutrients.
1.2 Humoral components of the innate immune system
The anatomical en (bio)chemical barriers are a passive part of the innate immune system, but
the innate immune system is also able to recognize Microbial Associated Molecular Patterns (PAMPs)
and will respond to these. These PAMPs consist of microbial structures like lipopolysaccharide (LPS),
peptidoglycan, bacterial DNA (CpG motifs) and double stranded RNA, that are conserved between
many different microbes. Humoral (=soluble) components of the innate immune system that can
recognize PAMPs are the complement system and acute phase proteins (like C-reactive protein).
Recognition of bacteria by these systems results in an amplification reaction that can either kill the
microbe directly by forming holes in the bacterial membrane or promotes it destruction by recruitment
of immune cells (inflammation) and “tagging” the microbe for killing by the recruited phagocytic
immune cells.
1.3 Cells of the innate immune system
The cellular part of the innate immune system consists of the granulocytes (neutrophils, mast
cells, basophils and eosinophils), the phagocytic antigen presenting cells (macrophages and dendritic
cells) and the natural killer (NK) cells.
Mast cells are a type of innate immune cell that reside in connective tissue and in the mucous
membranes. When activated directly by certain microbial products or products of the activated
complement system, mast cells rapidly release histamine and tumor necrosis factor alpha (TNFa), that
will cause recruitment of  immune cells (like granulocytes and macrophages) into the tissue a process
known as “inflammation”.  Basophils have a very similar function as mast cells, but are normally
present in the blood. They can be recruited from the blood to sites of infection to contribute to the
recruitment of other immune cell, e.g. neutrophils. Neutrophils are the most abundant type of
phagocyte, normally representing 50 to 60% of the total circulating leukocytes (= white blood cells)
whose primary function is to phagocytose and destroy bacteria and single cell fungi at the site of
infection.
Natural killer cells, or NK cells, are a component of the innate immune system that destroys
virus-infected cells, thereby limiting the viral replication.
Macrophages are large phagocytic cells present in the tissues that are differentiated from
monocytes in the blood. They can phagocytose and kill substantial numbers of bacteria or other cells
or microbes. Upon recognition of microbes (PAMPs) they can produce cytokines like TNFa, IL-1, -6,
and -8 that promote inflammation, to clear the infection.
114 | Livestock Research Report 800
Dendritic cells (DC) are phagocytic cells present in tissues that are in contact with the external
environment, mainly the skin (where they are often called Langerhans cells), and the inner mucosal
lining of the nose, lungs, stomach, and intestines. Dendritic cells are very important in the process of
antigen presentation, and serve as a link between the innate and adaptive immune systems. With
their many Pattern Recognition receptors (PRR), like Toll like receptors, that can bind to PAMPs they
can sense microbial danger. They are the most important cell in the immune system for orchestrating
the right kind of immune response for a particular microbe.  Depending on the microbial danger that is
sensed, they will secrete a cocktail of cytokines that will activate the appropriate immune cells. They
can activate antigen specific T cells of the adaptive immune system.
Gamma delta T cells (γδ T cells), represent a small subset of T cells in the blood of humans
but are present in relatively larger numbers in the blood of cows and pigs. They consists of several
subtypes and can perform  many of the functions that conventional αβ (alpha beta) T  cells can also
perform, including killing of infected or stressed cells and secretion of many immune modulating
cytokines. Gamma delta T cells exhibit characteristics that place them at the border between innate
and adaptive immunity. On one hand, γδ T cells may be considered a component of adaptive immunity
in that they rearrange T cell receptor (TCR) genes to produce diversity and because they can develop
to a certain extend a memory phenotype. However, the various subsets may also be considered part
of the innate immune system where a restricted set of  TCR receptors may be used as a pattern
recognition receptor (PRR) able to recognize conserved microbial structures or other signs of danger.
For example, according to this paradigm, large numbers of Vγ9/Vδ2 T cells respond within hours to
common molecules produced by microbes, and highly restricted intraepithelial Vδ1 T cells will respond
to stressed epithelial cells. Gamma delta T cells are more abundantly present in the mucosa where
they will be one of the first cells to encounter invading pathogens. Still many questions about these
cells remain to be resolved.
2. The adaptive immune system
In contrast to the innate immune system the adaptive immune system is able to very specifically
recognize pathogens. A second important difference with the innate immune system is that it has
“memory” so that in future encounters with the same pathogen it can mount a much faster and
stronger immune response compared with the first encounter. The cells of the adaptive immune
system are T cells and B cells.  The both contain antigen specific receptors on their surface that are
generated by a process called “gene rearrangement”. This process ensures that many different B and
T cells are generated of which each cell has one kind of B or T cell receptor with its own unique
antigen binding site. During an infection, only B or T cells that can bind with their receptor to the
invading pathogen will be selected  and will start to proliferate. The process of selection and
proliferation takes approximately a week till enough antigen specific B and T cells are generated to
mount an effective adaptive immune response. The T cells consist of cytotoxic T cells (CTLs) that can
kill virus infected cells and T-helper (Th) cells that are involved in “helping” the appropriate effector
cells. T-helper-1 (Th1) cells will e.g. help macrophages to become more effective in killing
phagocytosed microbes and will promote the development of CTLs, while Th17 cells promote the
recruitment of neutrophils to the site of infection. B cells often also require the help of Th2 or Th1 cells
to become fully activated and finally develop into antibody secreting plasma cells. The antibodies form
the humoral part of the adaptive immune system.
2.1 Antibodies
In humans 5 antibody isotypes are produced: IgA, IgD, IgE, IgG and IgM. They all consist of 2 light
and 2 heavy chains that together form a Y-shaped protein (T-shaped in the case of IgA). The variable
part of the heavy and light chains form the antigen binding sites (2 identical ones for each monomeric
antibody), while the constant part of the heavy chains form the Fc part of the antibody that
determines what will happen with the antigen/microbe bound by the antibody. Depending on the
antibody isotype this could e.g. be activation of complement or binding to Fc receptors on phagocytic
cells to enhance uptake of the antigen/microbe by these cells. IgG is the principle isotype in serum
while IgA is the principle antibody in the gastro intestinal tract and of other mucosal surfaces including
the upper respiratory tract.
The mucosal immune system
Of all antibody producing cells in the body 70 to 80% are physically located within the tissues of the
mucosal immune system. The majority of these are IgA producing B cells.
Mechanistically, the induction process can be divided into the following steps:
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• Antigens entering the digestive tract are taken up by specialized mucosal cells called M cells.  M cells
internalize the antigen and transport it across the epithelium where antigen can be taken up by APCs
such as dendritic cells (DC).  “M” cells are formed in mucosal epithelium in response to signals from
lymphocytes.
•  Antigen can be taken up by DC that have dendrites extending through the epithelial tight junction
into the lumen (drawing on right). Antigens are then presented to lymphocytes (in the intestine, these
are located in Peyer’s patches).
• Lymphocytes (both B and T cells) leave the mucosal site and travel to the mesenteric lymph nodes,
then into the lymph.
• Via the thoracic duct, the lymphocytes exit the lymph and enter the circulation.
• Circulating lymphocytes “home” to positions within the mucosal lamina propria throughout the body,
including sites distant from the original antigenic encounter. The homing of lymphocytes to mucosal
sites involves specific interactions of both adhesion molecules and chemokines.
• B Lymphocytes within the peripheral tissues proliferate and differentiate into IgA secreting plasma
cells at effector sites.
C.  Features of Mucosal Immunity
1.  The administration of antigen at one mucosal site results in specific antibody production at distant
mucosal sites (the common mucosal immune system). Some regional preference seems to occur,
however.  For example, induction via NALT (nasal associated lymphoid tissue) leads to a more robust
response in the respiratory sites than in induction via mucosal associated lymphoid tissue (MALT) in
the intestine.
2.  B cells in the mucosa are selectively induced to produce dimeric IgA rather than other isotypes.
The selective switch of B cells to IgA is believed to be mediated by specific cytokines produced by T
cells in the inductive sites.
3. A distinct population of lymphocytes, mostly CD8+ T cells are found in the gut epithelium.  Many of
these intraepithelial lymphocytes are γδ T cells that have an innate character. They can recognize
microbial structures with their γδ T cell receptor and respond to invading microbes.
4.  Conventional T cells, particularly CTLs, are also an important component of the mucosal immune
response. The induction and homing requirements for these cells are not as well described as those
for mucosal B cells.
5.  Induction of a response via a mucosal site generally elicits a systemic immune response as well,
such that serum antibodies can be detected. This indicates that a mucosal encounter with antigen
generates subsets of T and B cells that home to mucosal sites and also to spleen and regional nodes.
6. Regulatory T cells are a prominent feature at mucosal sites, and may synergize with suppressive
dendritic cells. Regulatory populations have been isolated from draining lymph nodes of mucosal sites.
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Wageningen UR Livestock Research develops knowledge for meticulous and
profitable livestock farming. This is then translated into practical solutions
and innovations, all the while, ensuring the dissemination of this knowledge.
Together with our clients, we combine our scientific knowledge in the field of
livestock farming systems and nutrition, genetics, health and environmental
impact of livestock into workable livestock concepts for the 21st century.
The mission statement of Wageningen UR (University & Research centre) is
‘To explore the potential of nature to improve the quality of life’. Within
Wageningen UR, nine specialised research institutes of the DLO Foundation
and Wageningen UR have joined forces in order to contribute to the solution
of pressing questions in the field of healthy food and living environment. With
around 30 branches, 6,000 employees and 9,000 students, Wageningen UR
is one of the most prestigious knowledge institutes in its field worldwide. The
integrated approach to problems and the collaboration between different
disciplines, form the core of Wageningen’s unique approach.


Together with our clients, we integrate scientific know-how and practical experience 
to develop livestock concepts for the 21st century. With our expertise on innovative 
livestock systems, nutrition, welfare, genetics and environmental impact of livestock
farming and our state-of-the art research facilities, such as Dairy Campus and Swine 
Innovation Centre Sterksel, we support our customers to find solutions for current 
and future challenges.
The mission of Wageningen UR (University & Research centre) is ‘To explore 
the potential of nature to improve the quality of life’. Within Wageningen UR, 
nine specialised research institutes of the DLO Foundation have joined forces 
with Wageningen University to help answer the most important questions in the 
domain of healthy food and living environment. With approximately 30 locations, 
6,000 members of staff and 9,000 students, Wageningen UR is one of the leading 
organisations in its domain worldwide. The integral approach to problems and 
the cooperation between the various disciplines are at the heart of the unique 
Wageningen Approach.
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